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Abstract	  
 
Purpose: Irreversible retinal ganglion cell (RGC) death is the reason for visual loss in 
glaucoma. However, the mechanisms of RGC death remain unclear. The aim of this research 
was to develop methods to study mRNA expression profiles in human RGCs, then to use the 
data to investigate the role of calcium in RGC death.  
 
Methods:  A planar sectioning technique was developed to isolate mRNA from serial sections 
of the human retina. QRT-PCR of neuronal markers validated the technique. Global gene 
expression analysis, using Illumina arrays, compared expression in the retina ganglion cell 
layer (RGCL) and entire macula (Mac). Immunohistochemistry and QRT-PCR validated 
gene array data. RGC death was investigated using a simulated ischemia (oxygen glucose 
deprivation, OGD) model in human organotypic retinal cultures (HORCs). Cell survival was 
measured by LDH, and RGC loss by immunohistochemistry and QRT-PCR. Western blot 
assessed proteases.  
 
Results: The sectioning technique developed enabled isolation of relatively large quantites of 
high quality mRNA from 20µm retinal sections from the macular region of the human retina.  
Marker genes for retinal neurons verified accurate profiling of gene expression across the 
retina.  Gene arrays provided a list of genes that were most enriched in the RGCL.  AHNAK2 
and HSPA1B were the two most enriched genes in the RGCL. CAPN1 (calpain 1), a calcium-
dependent cysteine proteases, was in the gene list. Its expression was confirmed to be mainly 
in the inner retina. OGD caused calpain activation and induced RGC death. Two TRP 
channels, TRPM-2 and TRPC-3, which mediate Ca2+ influx, were found that predominantly 
expressed in the RGCL. Involvement in RGC death in the OGD model using the TRP 
inhibitor ACA could not be confirmed. 
 
Conclusions:  The technique developed has enabled determination of the human RGCL 
transcriptome and has allowed expression profiling of gene of interest across the retina.  This 
could prove to be a powerful tool in the investigation of pathways involved in 
neurodegeneration in the retina. 
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Chapter 1 
Introduction 
1 Anatomy of the eye 
1.1 Gross anatomy 
The eye is a highly complex organ (Figure 1.1) with the primary function of photoreception. 
This is a precise physiological process, where the co-ordinated function of the components of 
the eye allows light energy to be transformed into electrical signals which are transmitted 
through the optic nerve to the brain, where the signal can be interpreted and perceived as an 
image. A full review of eye anatomy and function is given in Forrester (2002). 
 
The human eye is a spheroid approximately 2.5cm in diameter with a volume of 
approximately 6.5ml (Forrester, Dick et al. 2002). It is made of three layers (Figure 1.1). The 
outer layer is the fibrous coat, which consists of the cornea and sclera. These provide 
protection and structural support, as well as enabling light to enter the eye. The middle layer 
is the uvea, the vascular tract which is composed of the iris, the ciliary body and the choroid. 
The inner layer is the neural layer and includes the retina and retinal pigment epithelium 
(RPE). The interior of the eye contains the aqueous humour in the anterior, the vitreous 
humour in the posterior of the eye and the lens is situated between them. The following 
sections will describe the components of the eye in more detail, focussing primarily on the 
retina. 
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Figure 1.1 The human eye with a schematic enlargement of the retina. Image from  
http://www.best4glasses.co.uk/images/eyeball.jpg 
 
1.2 The Cornea 
The cornea is a transparent and avascular tissue. Its primary function is refraction of light into 
the eye, and the highest degree of refraction occurs at its surface. It has rich nerve supply via 
long ciliary nerves of the ophthalmic division of the trigeminal nerve. The cornea is also an 
important barrier helping prevent trauma and infection and also helps to maintain the shape of 
the eye.  
 
1.3 The Sclera 
The sclera is the white, opaque, viscoelastic outer fibrous coat of eye. It consists of 
connective tissue which gives it the properties required, most importantly its strength. This 
provides protection for the inner structures of the eye. The thickness of the sclera varies 
throughout the eye: the thinnest is where the extraocular muscles are attached and the thickest 
occurs at the lamina cribrosa where the optic nerve leaves the eye. 
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1.4 The Iris 
The iris is a circular disc consisting mainly of smooth muscle. It is the coloured part of the 
eye. The iris separates the space in the front of the lens into the anterior and posterior 
chamber. The iris smooth muscle controls the diameter of the pupil to regulate the amount of 
the light entering the eye. 
 
1.5 The Ciliary Body 
The ciliary body lies at the base of the iris (Figure 1.2). It is divided into the ciliary 
epithelium, the ciliary body stroma and ciliary muscle. The ciliary body performs several 
functions, including aqueous humor production from the ciliary epithelium (see below) and 
accommodation which allows the focusing of light by the action of the ciliary muscle. 
 
 
Figure 1.2 The anterior eye and the aqueous humour flow. The direction of the thick arrow is the 
pathway of aqueous humour flow, secreted from the ciliary body, passing through the posterior 
chamber to the anterior chamber and draining through the trabecular meshwork and Schlemm’s canal. 
Image from http://www.littlerockeye.com/wp-content/uploads/2012/09/LI_1.jpg    
 
 
1.6 The Choroid 
The choroid is the posterior portion of the uvea. It lies between the retina and the sclera and 
adheres to the RPE by Bruch’s membrane. The choroid has an abundance of blood vessels 
and pigmented cells. The human choroid consists of five layers: Bruch’s membrane, the 
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choriocapillaris, two blood vessel layers and the suprachoroid. As it is enriched with blood 
vessels, the main responsibility of the choroid is to nourish the outer layer of retina. 
 
1.7 The Anterior and posterior chambers/ aqueous humour 
The anterior chamber is located between the iris and the cornea (Figure 1.2). Within the 
anterior chamber there are several important structures, including Schlemm’s canal, the 
scleral spur, the iris root, the trabecular meshwork and the ciliary muscle. Schlemm’s is the 
channel that the aqueous humour flows through to allow drainage from the eye. In this way, it 
helps maintain normal intraocular pressure (IOP) and also removes waste products from the 
anterior eye. The trabecular meshwork is divided into three parts: the uveal meshwork, the 
corneoscleral meshwork, and the cribriform meshwork. The latter provides the greatest 
resistance to aqueous outflow and is therefore of most significance in control of IOP. The 
trabecular meshwork is situated between the cornea and the iris (Figure 1.2). This area is 
referred to as the angle. The aqueous humour is watery liquid that fills the space of the 
anterior and posterior chambers. It is secreted by the ciliary epithelium of ciliary body into 
the posterior chamber (the space between the lens and the iris), passes around the lens and 
flows through the pupil into the anterior chamber and drains at the angle via the trabecular 
meshwork and Schlemm’s Canal (Figure 1.2). The aqueous humour supplies the nourishment 
to the lens and the cornea. It also plays an important role in maintenance of the shape of the 
eye via the IOP. The IOP is normally in the range of approximately 10-21mmHg with a mean 
of approximately 16mmHg. A balance of secretion and drainage of aqueous humour 
maintains normal IOP.  
 
1.8 The Lens 
The lens is located behind the iris and is held in place by the suspensary ligaments which are 
connected and distance to the ciliary body (Figure 1.2). The lens is an important component 
in the refractive system of the eye and is responsible for the fine focussing of light on the 
retina. The shape of the lens is controlled by the ciliary muscle, which on contraction 
increases the curvature of the lens. By doing this, the refraction of light by the lens will be 
modulated, in order to focus light from near objects onto the retina. When the ciliary muscle 
is relaxed, the lens is pulled and flat and taut by the IOP, enabling focussing of light from 
distance objects. 
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1.9 The Vitreous Humour 
The vitreous humour is a transparent viscoelastic gel and occupies approximately 80% of the 
cavity of the eye posterior to the lens. The vitreous humour consists of water (98-99%), 
proteins, and collagen. It is used to maintain the shape of the eye and help keep the retina 
attached to the RPE and choroid. 
 
1.10 The Retina 
The retina is located at the internal face of the choroid and it is also the innermost layer of the 
eye. It is made up of the neurosensory retina and the retinal pigment epithelium. The 
neurosensory retina contains millions of photoreceptors which convert light from the external 
environment into neural impulses. The retina is a multi-layered organ made up of multiple 
neuronal and non-neuronal cell types (Figure 1.3). The thickness of the retina varies: the 
thickest area is close to the optic nerve, which is over 0.23 mm. The optic disc is the area 
where ganglion cell axons exit the eye and it is also the entrance for the central retinal vessels. 
It is approximately 1.5mm-1.75mm in diameter and there are no photoreceptors located in 
this area. No visual transduction can therefore occur here which is known as the “blind spot”. 
The central retina, also known as posterior pole, is a 5-6 mm diameter circular region called 
the macula lutea. The macula lutea appears yellow in colour, which is an important anatomic 
characterization, due to the abundance of xanthophyll carotenoid pigment in this region 
which helps protect the retina. The fovea centralis (also called the foveola) is a 0.35 mm 
diameter area in the centre of the macula lutea. It is the most sensitive part of the retina and is 
where the image focuses. In this area, the cone photoreceptors reach maximum density, at 
almost 15000 cells/ mm2. Cone concentration decreases rapidly from the centre to the rim, 
where there are 4000-5000 cells/ mm2.  
 
 
 
 
20 
! ! 
Figure 1.3 Histological image (transverse section) of the retina (left) and schematic diagram of 
cells types of retina (right). Nerve fiber layer (NFL), ganglion cell layer (GCL), inner plexiform layer 
(IPL), inner nuclear layer (INL), outer plexiform layer (OPL), outer nuclear layer (ONL), outersegment 
(OS). Arrow (short)- retina pigment epithelium (RPE), arrow (long)-middle limiting membrane, 
arrowhead (upper)-outer limiting membrane, arrow (lower)-inner limiting membrane. Images from “the 
eye” www.theness.com/images/blogimages/retina.jpeg and 
www.vetmed.ucdavis.edu/.../archive/s_4661_a.jpg 
 
1.10.1 The Retina Pigment Epithelium 
The retinal pigment epithelium (RPE) is a monolayer of hexagonal cells, which extends from 
the optic nerve head to the ora serrata. The thickness of the RPE is greatest in the macula and 
tends to be thinner at the periphery. It has numerous functions, including maintaining 
adhesion of the neurosensory retina; acting as a barrier between the choroid and neurosensory 
retina (the blood-retinal barrier); absorbing light and reducing light scatter in order to 
improve image resolution and transporting and storing metabolites and vitamins. It also plays 
a key role in phototransduction, recycling the visual pigment to the photoreceptors as well as 
in maintenance of the photoreceptors, including turnover of the outer segment.  
 
1.10.2 The Neurosensory Retina 
Within the retina, there are several neuronal cell types, specifically photoreceptor cells (PR), 
horizontal cells (HC), amacrine cells (AC), bipolar cells (BC) and retinal ganglion cells 
(RGC). Their cell bodies are organised in three nuclear layers with PR nuclei in the outer 
 
 
 
21 
nuclear layer (ONL), HC, AC and BC nuclei in the inner nuclei layer (INL) and RGCs in the 
innermost layer (Figure 1.3).  
 
1.10.2.1 Photoreceptors 
There are two kinds of photoreceptors (Figure 1.3), the rods and the cones. Cones have a 
maximum density in the fovea, while rods are mainly present in the more peripheral retina. 
They are responsible for phototransduction: the transduction of light to an electrical signal. 
Cone photoreceptors are responsible for colour vision and enable high spatial but low light 
sensitivity. In the human, there are 3 types of cones which are sensitive to blue, green or red 
light. Rod photoreceptors have relatively low spatial acuity and low sensitivity to colour. 
However, they have highly light sensitivity for vision in low light environments, and are 
important in detection of motion. The foveal region contains the highest density of cone 
photoreceptors and a low density of rod photoreceptors; the peripheral retina contains the 
lowest density of cone photoreceptors and highest of rod photoreceptors. Photoreceptors are 
located in the outer layer of the retina and their nuclei make up the outer nuclear layer. 
 
1.10.2.2 Bipolar cells, Horizontal and Amacrine cells 
Bipolar cells are located in the mid-layers of the retina with their cell bodies in the inner 
nuclear layer (Figure 1.3). The dendrites of bipolar cells receive input from either cones or 
rods, giving two main types of bipolar cell, the rod bipolar type and cone bipolar type. At 
their distal end, bipolar cells synapse with ganglion cells transmitting the signal between 
these two cells. The ratio of bipolar/photoreceptor cells is higher in the central compared to 
peripheral retina, which enables greater acuity in the foveal region. The bipolar cells also 
have input from horizontal cells.  
 
Horizontal and amacrine cells are located in the outer and inner parts of the inner nuclear 
layer respectively. They can communicate laterally across the retina, modifying and 
integrating the information that comes from the photoreceptor and bipolar cells. 
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1.10.2.3 Ganglion cells 
Ganglion cells are located in the inner region of the retina and are the last part of the neuronal 
pathway in the retina (Figure 1.3). There are approximately 1.2-1.5 million retinal ganglion 
cells in the human retina. In the macula, there are up to seven layers of RGCs. This is because 
in this region there is up to 1 photoreceptor cell vs 1 RGC to enable high visual acuity. The 
thickness of the retinal ganglion cell layer decreases from the fovea (60-80um) to the 
peripheral retina (10-20um). Their cell bodies exist in the ganglion cell layer and their axons 
form the nerve fibre layer. At the optic disc, the ganglion cell axons assemble passing 
through the lamina cribrosa in the optic nerve head, to form the optic nerve.  
 
1.10.2.4 Retinal neuroglia 
The retinal neuroglia supports retinal neurons, with critical roles in assisting several 
processes, such as metabolic support, neurotransmitter uptake and immune function. Müller 
cells are the major glial cells in the retina (Figure 1.3). The cells extend from the inner 
limiting membrane to the outer limiting membrane with their nuclei in the INL. They 
ensheath blood vessels and neuronal cells. Astrocytes are mainly located between the nerve 
fibre layer and inner nuclear layer. They display a perpendicular direction to the neuronal cell 
bodies and Müller cells. Microglia cells are located predominantly in two areas: the junction 
between the nerve fibre layer and the ganglion cell layer and the junction of the inner nuclear 
layer and the outer plexiform layer. They provide immune function in the retina. 
 
1.11 The blood supply of the retina 
The retina is an extremely active tissue, consuming more oxygen than any other human tissue 
and it therefore requires a large blood supply. In the human, a branch from the central retinal 
vessel supports the inner two-thirds of retina, while the choroidal circulation supports the 
outer one-third. The central retinal artery comes from the ophthalmic artery and enters the 
eye via the optic disc. There are four branches: the superior nasal and temporal arteries and 
the inferior nasal and temporal arteries. There are also capillary networks throughout the 
retina. The density of capillaries in the macula is higher than any other part of the retina and 
the density reduces towards to the peripheral retina. In the central fovea, there is a 0.5mm 
diameter area that is capillary-free. The retinal veins are located with the retinal arteries, and 
the central retinal vein leaves via the optic nerve head. 
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1.12 Glaucoma 
1.12.1 What is glaucoma 
Glaucoma is an optic neuropathy resulting in a progressive and irreversible deficit of visual 
field, which is defined with both defects of optic disc structure and visual functions (Foster, 
Buhrmann et al. 2002; Agarwal, Gupta et al. 2009; Quigley 2011). The functional and 
structural defects are due to the progressive death of retinal ganglion cells and loss of their 
axons in the optic nerve (Quigley 2011). Glaucoma is the second leading cause of blindness 
in the world (Coleman 2003). 
 
1.12.2 Classification of glaucoma. 
Glaucoma is divided into primary and secondary glaucoma, according to the cause of the 
disease. It is further subdivided into open-angle glaucoma and closed-angle glaucoma (Figure 
1.4) according to the structural changes in the anterior chamber angle (Figure 1.4 & 1.5). 
Open angle glaucoma, the angle between the iris and the cornea remains open. In closed 
angle glaucoma, drainage through the trabecular meshwork is physically blocked by surround 
tissue. Primary open angle (POAG) and primary angle closure glaucoma (PACG) are further 
subdivided (Figure 1.4), depending on whether intraocular pressure is raised and natural 
history, respectively.  
 
Figure 1.4 Classification of glaucoma. Chart modified from the book Glaucoma identification & co-
management (Rudnicka and Owen 2007). 
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Figure 1.5 The comparison of primary open angle glaucoma (POAG) and primary angle closure 
glaucoma (PACG). In POAG there is a decrease in rate of drainage through the trabecular meshwork 
causing an increased IOP, but the angle remains open; in PACG the iris blocks the trabecular 
meshwork and the angle is closed.Image from “Med Rounds publications” 
http://webeye.ophth.uiowa.edu/dept/service/glaucoma/images/open-closed.jpg 
 
1.12.3 Prevalence and risk factors 
Population-based studies have shown that approximately 2.5% of people over 40 years have 
glaucoma worldwide (Quigley 2011). This causes significant levels of blindness, for example 
in China it has been shown that of 9.4 million people suffering from glaucoma, 55% of them 
are blind in one eye and 18.1% of them have fully lost vision of both eyes (Foster and 
Johnson 2001).  
The POAG is responsible for the majority of cases of glaucoma in white and black people in 
the America, Europe and Africa (Racette, Wilson et al. 2003; Weinreb and Khaw 2004; 
Giangiacomo and Coleman 2009), although it has recently been established that the 
prevalence of PACG is increasing in these areas (Day, Baio et al. 2012). In Asian countries, 
angle closure glaucoma is the major form of glaucoma (Foster and Johnson 2001; Foster, 
Buhrmann et al. 2002) and 87% of people with ACG worldwide are of Asian origin 
(Giangiacomo and Coleman 2009). 
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Intraocular pressure (IOP) is the key risk factor for glaucoma development. In the healthy 
condition, mean IOP is 16mmHg and normally ranges from 10 to 21 mmHg. The Barbados 
Eye Studies demonstrated that prevalence of OAG was closely related to the IOP level.  
Specifically, the study found that with each 1mmHg increase in IOP was increased the 
chance of developing OAG by approximately 12% (Nemesure, Honkanen et al. 2007). 
Furthermore, the Advanced Glaucoma Intervention study of PACG patients indicated that 
patients with IOP ≥ 16mmHg 5 years after initial intervention, had a greater loss of visual 
field compared to those with an IOP < 16mmHg (Inatani, Iwao et al. 2008). However, 
reducing IOP does not absolutely prevent progression of glaucoma (Hitchings 2004).  
In addition, elevated IOP is not an essential requirement for glaucoma development, and 
some glaucoma patients have normal intraocular pressure (NPG). Approximately 30-40% of 
POAG patients fail to show increased IOP but have visual defects (Hoyng and Kitazawa 
2002). Treating NPG by lowering IOP can slow down the progression of glaucoma, but still 
does not prevent the occurrence of glaucomatous neuropathy (Heijl, Leske et al. 2002). 
Although the causes of NPG are not clear, vascular dysregulation has been proposed as an 
important risk factor for NPG (Hitchings 2004) and ocular perfusion pressure fluctuations 
have been shown to play a significant role in visual field progression in NPG (Sung, Lee et al. 
2009). 
The IOP has been shown to slightly increase with age (Bonomi, Marchini et al. 1998). The 
prevalence of both of POAG and PACG is closely related to age (Foster and Johnson 2001; 
Yoshida, Okada et al. 2001) and epidemiological studies have reported that people who are 
over 70 years of age have 3-4 times the risk for glaucoma compared to people who are 
between 40 and 50 years old (Rudnicka and Owen 2007). Prevalence of glaucoma also relates 
to race. In American, black people have a six times higher chance of getting POAG compared 
with white people of the same age. Progression of POAG is also more rapid in black people 
compared to white (Racette, Wilson et al. 2003). Also, people who have myopia have a 
higher risk of glaucoma. In the Blue Mountains Eye Study, based on 3654 Australians aged 
49 to 97 years old, people with myopia were found to have a 2 to 3-fold higher risk of 
developing glaucoma compared to non-myopia people independent of other factors (Mitchell, 
Hourihan et al. 1999; Giangiacomo and Coleman 2009). Family history is another high risk 
factor for glaucoma (Tielsch, Katz et al. 1994; Kong, Chen et al. 2011). For example, in the 
study of a Chinese population, it has been found that the siblings of patients with PACG had 
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as high as a 50% chance of heritability of a narrow angle and therefore susceptibility to 
PACG (Amerasinghe, Zhang et al. 2011). 
1.12.4 Diagnosis of glaucoma 
To diagnose glaucoma, several tests are performed, including measurement of IOP, visual 
field tests and optic nerve assessment. Tonometry is the most common method to measure the 
IOP.  However, as discussed earlier, IOP is not always raised in patients with glaucoma.  In 
glaucoma, there is a loss if visual field, therefore perimetry checks are used to detect whether 
visual field is affected. In addition, optic nerve head examination is used to determine the 
presence of glaucoma. In the healthy retina, there are about 1.2 million ganglion cell axons 
exiting the eye at the optic nerve head. Since retinal ganglion cells die in the glaucoma, their 
axons are lost and this can be detected at the optic nerve head. The optic cup is enlarged in 
glaucoma patients (Figure 1.6) (Garway-Heath, Ruben et al. 1998; Williams 2007). Normally, 
the ratio of cup size/ disc size is smaller than 0.5 and increases in glaucoma. However, this 
number may be variable between patients, including effects of race (Garway-Heath, Ruben et 
al. 1998). Therefore, if a patient has one of the following conditions, it is proposed the optic 
disc has been damaged by glaucoma (Williams 2007): 
1. The ratio of cup size/disc size is above 0.5. 
2. The vertical cup/disc ratio is bigger than the horizontal cup/disc ratio. 
3. There is asymmetry between the cup/disc ratios of the two eyes of more than 0.2. 
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Figure 1.6 The optic nerve head and optic cup. The optic cup is located at the center of the optic 
nerve head. In the normal optic nerve head (left) the ratio of cup size to optic disc size is approximate 
0.3; in the glaucoma one (right) the ratio is approximate 0.9. Image from http://www.e-
sunbear.com/glauc_diag.html 
 
1.13 Pathogenesis of glaucoma 
There are two main hypotheses relating to the pathogenesis of glaucoma, the mechanical 
hypothesis and the vascular hypothesis. The mechanical hypothesis relates to damage as a 
result of elevated IOP. The vascular hypothesis relates to vascular dysregulation resulting in 
decreased blood flow to the retina leading to RGC cell death.  
It is most likely that the pathological process involves both of these factors and that in most 
cases (where IOP is raised) they act together to lead ultimately to occurrence of 
neurodegeneration in the glaucoma. Each hypothesis is described in further detail below.  
 
1.13.1 The mechanical theory of glaucoma 
Intraocular pressure plays an important role in maintaining physiological function and 
structure of the eye. However, elevated IOP is the primary risk factor for glaucoma and leads 
to structural and functional defects (Quigley 2011). It has been shown that raised IOP leads to 
RGC death in many experimental models, including in mouse (Tsuruga, Murata et al. 2012), 
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rat (Biermann, Oterendorp et al. 2012), rabbit (Solomon, Kimron et al. 2003), monkey 
(Sasaoka, Nakamura et al. 2008) and pig (Ruiz-Ederra, Garcia et al. 2005).  
Increased IOP has been shown to affect the stress-strain in the optic nerve head. The forces 
on the scleral shell, the lamina cribrosa and the scleral canal are proposed to ultimately lead 
to damage to the retinal ganglion cell axons causing death of the RGCs (Claude, Burgoyne et 
al. 2005) (Figure 1.7). The lamina cribrosa is considered as a weak spot biomechanically 
because of its discontinuity with the corneo-scleral shell (Downs, Roberts et al. 2011; 
Strouthidis and Girard 2013). The lamina cribrosa is where retinal ganglion cell axons exit 
the eye globe (Strouthidis and Girard 2013). Figure 1.7 shows a model to demonstrate the 
compressive strain in the lamina region with IOP at the normal level (15mmHg) and elevated 
level (25mmHg). Retinal optic nerve head (ONH) start to remodel when exposed chronically 
to elevated IOP and eventually changes its morphology becoming “cupped” (Downs, Roberts 
et al. 2011). Elevated IOP has been shown to change the specific extracellular matrix (ECM) 
in the retinal ganglion cell layer, and ECM remodeling is a proposed link with RGC death in 
glaucoma (Guo, Moss et al. 2005). 
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Figure 1.7 Prediction model of IOP-related tensile strain in the lamina region. The of tensile 
strain impact in the optic nerve head of  (middle) normal IOP (12.5mmHg) and (bottom) elevated IOP 
(25mmHg) were predicted (Downs, Roberts et al. 2011).   
 
 
The stress-strain from elevated IOP has also been shown to affect axoplasmic transport at the 
point that the axon passes through the lamina cribrosa (Guo, Moss et al. 2005). Early 
experiments in a monkey model of glaucoma showed that when IOP was elevated moderately 
there was an incomplete blockade of transport at the lamina cribrosa, and a complete 
blockade occurred when the IOP was elevated to 25mmHg (Anderson and Hendrickson 
1974). With acute elevation of IOP to 30mmHg, blockade of transport was observed within 1 
hour at the lamina cribrosa (Anderson and Hendrickson 1974; Quigley and Anderson 1976), 
indicating that flow along the axon from the brain to the retina (retrograde) was being 
interrupted. The retina axonal transport obstruction at the lamina cribrosa was independent of 
blood supply indicating that mechanical compression rather than decreased blood flow was 
responsible for the changes was observed (Minckler, Bunt et al. 1977; Geijer and Bill 1978). 
Further experiments showed that there was an interruption to axonal transport in both 
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orthograde and retrograde directions (Minckler, Bunt et al. 1977). Significantly there was a 
lack of movement of neurotrophin from the brain to the retina. Neurotrophin has an essential 
and potent effect on neurons survival (Almasieh, Wilson et al. 2012). In particular, brain 
derived neurotrophic factor (BDNF), transports retrogradely to the RGCs and has been shown 
to have a protective role in RGCs survival under axonal insult (Quigley, McKinnon et al. 
2000; Almasieh, Wilson et al. 2012). BDNF was found to be deprived in the ONH and 
superior retina when exposed to 40mmHg IOP for 7days (Johnson, Deppmeier et al. 2000). 
Overexpression of BDNF in the rat glaucomatous model using gene therapy, promoted RGC 
survival compared to untreated group (Martin, Quigley et al. 2003). Therefore, BDNF 
deprivation as a result of mechanical stress at the optic nerve head may play an important role 
in IOP induced RGCs death.  
 
1.13.2 Vascular factors 
Abnormalities of retinal blood flow are associated with glaucoma (Yanagi, Kawasaki et al. 
2011) and the age-related decrease in perfusion to the brain and the eye has been identified as 
an important risk factor for glaucoma (Guo, Moss et al. 2005; Agarwal, Gupta et al. 2009). 
Reduction of retinal blood flow can occur directly via changes to retinal perfusion or 
indirectly due to IOP elevation. Due to the high oxygen requirement of the retina, it requires a 
large amount of blood flow, supplied from the central retinal artery and choriocapillaris 
(Figure 1.8). The ocular blood flow provides nutrients and oxygen to meet the metabolic 
requirement of the retina. Therefore a reduction in blood flow will limit this supply. In 
addition, interruption of blood flow also causes accumulation of metabolic waste (Osborne, 
Casson et al. 2004). These factors are all proposed to contribute to RGC death in glaucoma.  
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Figure 1.8 Diagram of retinal blood supply showing distribution to the retina, optic disc and 
optic nerve. OD, optic disc; LC, lamina cribrosa; R, retina; C, choroid; S, sclera; ON, optic nerve 
(Hayreh 2008).  
 
 
Reduced retinal blood flow can be caused by IOP induced lamina cribrosa deformation. The 
central retina vessels pass through the lamina cribrosa, therefore, retinal vessels will be 
compressed when the lamina cribrosa is strained by elevated IOP (Hayreh 2008). 
Furthermore, IOP elevation also can reduce blood flow by impacting of perfusion pressure. 
Clinically, ocular perfusion pressure (OPP) is down-regulated with increased IOP and up-
regulated by increased mean blood pressure (BPm). The equations are shown below (BPd = 
diastolic blood pressure; BPs = systolic blood pressure) (Okuno, Sugiyama et al. 2004).   
 
 
 
There has been much research into the effect of ischemia on the retina. Experimental studies 
of retinal ischemia in vivo are mostly induced by IOP elevation or retinal artery ligation. It 
has been shown previously that the retina can tolerate relatively short periods of acute 
ischemia without irreversible damage (Sohan and Thomas 1980; Selles-Navarro, Villegas-
Perez et al. 1996).  However for more extended periods of ischemia RGC death is observed 
over the following reperfusion period. Elevating IOP to induced retinal ischemia (Nucci, 
Tartaglione et al. 2005; Huang, Fileta et al. 2010; Biermann, van Oterendorp et al. 2012) has 
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shown pathological features which are similar to those that occur in glaucoma patients 
(Nucci, Tartaglione et al. 2005). Inducing retinal ischemia in the rat by elevating IOP for 
60min followed by 10 days reperfusion caused retina ganglion cell number to reduce with 
some inner retinal layer thinning compared with the outer retinal layers (Osborne, Ugarte et 
al. 1999). This suggested that RGCs are vulnerable to ischemic stimulation. Using the same 
rat model it has also been shown that the RGC number was reduced significantly and the cell 
loss was increased as the reperfusion time was prolonged (Selles-Navarro, Villegas-Perez et 
al. 1996; Nucci, Tartaglione et al. 2005). This may suggest that there is a secondary loss of 
following the initial ischemic insult. In human retinal explants, it has also been shown that 
simulated ischemia (oxygen/glucose deprivation) leads to RGC death (Niyadurupola, 
Sidaway et al. 2011). Experimental evidence therefore indicates that retinal ischemia causes 
RGC death supporting the hypothesis proposing a vascular contribution to glaucoma 
pathophysiology. 
 
1.13.3 Excitoxicity 
Glutamate is the most common excitatory neurotransmitter in the retina and necessary for 
neural communication in the retina (Thoreson and Witkovsky 1999). However, it is 
neurotoxic in concentrations that are higher than the normal physiological level (Choi and 
Rothman 1990). It has been shown to be released excessively by retinal cells under 
conditions that simulate the pathological situation (Osborne, Melena et al. 2001). For 
example, in retinal ischemic insult, glutamate level was shown to increase drastically (Neal, 
Cunningham et al. 1994; Osborne, Ugarte et al. 1999) and excessive glutamate has been 
shown to be toxic to RGCs (Vorwerk, Lipton et al. 1996; Yasumasa, Wei et al. 1998; Martin, 
Levkovitch-Verbin et al. 2002).  
It has been shown that retinal ganglion cells highly express both NMDA receptor as well as 
non-NMDA glutamate receptors (Chen and Diamond 2002; Shen, Liu et al. 2006; Zhang and 
Diamond 2006). NMDA receptors are the primary glutamate receptors relevant to 
excitoxicity which is triggered by increased glutamate level (Agarwal, Gupta et al. 2009). 
NMDA receptors are non-selective cation channels and are highly permeable to Ca2+ and Na+. 
The excessive extracellular glutamate leads to NMDA receptors being over stimulated, which 
result in prolonged calcium influx, which in turn mediates cell death (Ikeda, Dawes et al. 
1992). 
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 Mg2+ is a voltage-dependant ion blocker for NMDA receptors (Zeevalk and Nickias 1992; 
Osborne, Casson et al. 2004). During retinal ischemia, the energy failure, and spatial loss of 
ATP, leads to decrease activity of the Na+/K+-ATPase consequently affecting membrane 
potential, causing the cells to remain depolarized. In depolarized cells, the Mg2+ block of the 
NMDA receptor is lifted, further contributing to NMDA receptor action during retinal 
ischemia (Almasieh, Wilson et al. 2012). In addition, depolarization is caused by non-NMDA 
glutamate receptors, lifting the Mg2+ block and contributing to over-activation of the NMDA 
receptor to induce excitotoxicity. 
The glutamate transporting system has also be shown to be affected during the retinal 
ischemia (Barnett, Pow et al. 2001). Glutamate uptake was predominantly by Müller cells, 
which have a major role in maintaining glutamate at low levels under normal physiological 
conditions in the retina (Barnett, Pow et al. 2001; Casson 2006). However, the function of 
Müller cells is also compromised when exposed to excessive extracellular glutamate. The 
process of Müller cell uptake of glutamate is dependent on the level of ATP, since it is driven 
by the Na+ and K+ gradient which is maintained by the Na+/K+-ATPase (Casson 2006). 
During retinal ischemia, ATP deficiency will therefore further elevate glutamate levels due to 
the loss of activity of the transport mechanisms. As the failure of Na+/K+-ATPase, 
intracellular Na+ concentration will rise which reverses the glutamate uptake transport into 
Müller cell (Napper, Pianta et al. 1999; Barnett, Pow et al. 2001).  
One of the important mechanisms of excitoxicity induced cell death in retinal cells is increase 
Ca2+ influx which causes intracellular Ca2+ overload and death of neurons (Osborne, Ugarte et 
al. 1999). NMDA receptors are highly calcium permeable (Osborne, Casson et al. 2004) and 
therefore when they are activated by excessive glutamate and allow massive calcium influx 
(Choi and Rothman 1990), that will stimulate calcium dependent and related processes 
consequently which eventually lead to cell death . 
 
1.13.4 Mitochondrial dysfunction and oxidative stress 
The mitochondria is a crucially important organelle in maintaining cellular homeostasis and 
can be described as an “energy factory” which produces ATP by oxidative phosphorylation, 
and supplies the majority of ATP requirements for cell fucntion. It also has other roles to play 
including regulation of intracellular Ca2+ concentration, which will be described in the 
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following section. Moreover, mitochondria involved in cell apoptosis by generating reactive 
oxygen species (ROS), and releasing apoptotic proteins into the cytosol, such as cytochrome 
C (Cheung, Yip et al. 2003; Osborne 2010).  
 
Mitochondria dysfunction has been hypothesized as an important factor in glaucoma 
progression. Glaucoma is an age-related retinal neurodegeneration (Mitchell, Smith et al. 
1996; Kong, Van Bergen et al. 2009), and mitochondrial function declines in efficiency as 
age increases (Chan 2006). Moreover, it is proposed that disruption to mitochondrial function 
by retinal ischemia or elevated IOP leads to the loss of supply of ATP to the RGCs (Osborne 
2010). This has been observed in the mouse optic nerve, where a decrease in ATP content 
was seen with age, and this decrease was promoted by elevated IOP and is proposed to 
contribute to RGC axonal loss (Baltan, Inman et al. 2010). 
 
The depletion of ATP also impacts the ATP-dependent ion transport, such as the 
sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) and Na+, K+-ATPase. Approximately 
60% of energy in the brain is consumed by cation transport through Na+, K+-ATPase and 
SERCA under the physiological conditions (Ames 2000). Ion homeostasis is essential for 
neuronal cell function. 
 
Further to this, ROS are generated constantly by normal metabolic activities in the 
mitochondia, such as oxidative phosphorylation and redox reactions (Brasnjevic, Hof et al. 
2008). They are removed by antioxidant enzymes, like catalase and glutathione peroxidase, 
which are necessary to keep physiological homeostatic conditions. Some primary antioxidant 
enzymes have been found to have decreased activities in peripheral blood of  patients with 
POAG (Majsterek, Malinowska et al. 2011), which resulted in accumulation of ROS. 
 
Above all, regardless of the primary insult, calcium is an important intermediary to determine 
cell life or death. Elevation of calcium influx is one of the crucial factors mediating cell death 
(Figure 1.10).  
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Figure 1.9 The pathology of glaucoma (Williams 2007). 
 
 
1.14. Calcium 
Calcium is an essential element in maintenance of normal physiological function of cells 
(Berridge 2004). It is a versatile and universal messenger regulating intracellular 
physiological processes, such as fertilization, proliferation, metabolism and secretion 
(Berridge, Bootman et al. 1998; Berridge, Lipp et al. 2000). Disruption of cellular 
homeostasis of calcium therefore impacts directly on physiological function, which in turn 
could lead ultimately to cell death. Calcium regulation is therefore of great interest in relation 
to the pathophysiology of numerous diseases, including glaucoma. 
 
1.14.1. Mechanisms of intracellular calcium homeostasis and signaling 
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Figure 1.10 Intracellular calcium regulation and cell signaling. ER/SR: endoplasmic/sarcoplasmic 
reticulum, NCX: Na+/Ca2+ exchanger, PCMA: plasma-membrane Ca2+- ATPase, SERCA: 
sarco(endo)plamic reticulum Ca2+- ATPase. Image from Berridge, 2003. 
 
 
In the normal physiological situation, the intracellular calcium ion concentration is typically 
0.1-1µM in the resting cell, which is around 10,000 times lower than the extracellular 
concentration (Hernandez-Fonseca and Massieu 2005). The cell is able to maintain the large 
electrochemical gradient, which in turn enables calcium signaling, due to the cooperation of 
Ca2+ pumps, exchangers and channels, which are present on the plasma membrane and 
membranes of the intracellular organelles (Figure 1.10).  
 
1.14.2. The “off ” reactions 
In order to maintain intracellular Ca2+ homeostasis, there are a number of processes which 
remove Ca2+ from the cytoplasm (shown as the  “off reaction” in Figure 1.10). The Na+ / Ca2+ 
exchanger (NCX) and the plasma membrane Ca2+-ATPase (PMCA) play principal roles in 
exporting Ca2+ from the cytoplasm against its electrochemical gradient to prevent Ca2+ 
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overload in cytoplasm (Guerini, Coletto et al. 2005). The NCX is a low affinity exchanger but 
has high Ca2+ transporting ability. NCX typically exchanges 3 Na+ for 1 Ca2+. Because the 
exchanger is driven by the Na+ gradient, the rate of extrusion of Ca2+ by the NCX is reduced 
when the intracellular Na+ concentration is increased (Guerini, Coletto et al. 2005). ATP 
levels and low cellular pH will also affect the exchanger because they will increase 
intracellular Na+ concentration (Lee, Yu et al. 1994)). Importantly, the NCX can switch 
directions and allow Ca2+ influx once a critical concentration of Na+ is reached.  
 
In mammalian cells, the Na+/Ca2+ exchanger comprises three isoforms, NCX1-3. It has been 
observed that NCX2 and NCX3 are highly expressed in the rat CNS (Lee, Yu et al. 1994). It 
has been reported that NCX1 is expressed throughout all the mouse retinal layers with higher 
density in the RGCL and IPL (Inokuchi, Shimazawa et al. 2009). Extraordinarily, the 
exchanger in the retinal rods and cones cells has been shown to import 4 Na+ and extrude one 
Ca2+ and one K+ (Cervetto, Lagnado et al. 1989; Prinsen, Szerencsei et al. 2000). 
 
The plasma membrane Ca2+-ATPase (PMCA) has a high Ca2+affinity but low Ca2+ 
transporting capacity. PMCA can transport 1 Ca2+ when 1 molecule of ATP is hydrolyzed. 
PMCA is mainly regulated by calmodulin via the C-terminal region of the pump which 
contains a calmodulin-binding domain (Guerini, Coletto et al. 2005). When the level of 
intracellular Ca2+ is raised, Ca2+ combines with the calmodulin, which then binds to the 
calmodulin-binding domain, and the pump is activated. The C-terminal region also contains 
many others regulatory domains, such as phosphorylation sites for protein kinase A (PKA) 
and protein kinase C (PKC). 
 
There are four isoforms of PMCA (PMCA1-4). PMCA1 and 4 are extensively expressed in 
human tissue, but PMCA2 and 3 are selectively expressed in the brain and heart (Guerini 
1998). In the mammalian retina, all the PMCA isoforms were detected (Koulen, Fletcher et al. 
1998; Krizaj, Demarco et al. 2002). Both PMCA2 and 3 highly stain the RGCL, IPL and 
inner side of INL (Krizaj, Demarco et al. 2002).  
 
There are two stores for Ca2+ inside the cell: the endoplasmic reticulum (ER) and the 
mitochondria. The ER store is the most dynamic and is the principle source of intracellular 
Ca2+ used in Ca2+ signaling. The sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) and 
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the mitochondrial Ca2+ uniporter remove free Ca2+ from the cytosol. The hydrolysis of ATP 
provides power to the SERCA pump to transport 2Ca2+ ions into the ER store against its 
electrochemical gradient. There are three isoforms of SERCA that have been identified, 
SERCA-1, SERCA-2 and SERCA-3.  
 
In the mammalian retina, there has been shown to be no expression of SERCA-1 isoforms, 
whilst SERCA-2 isoforms are highly expressed in most mammalian retinal neurons, 
compared to SERCA-3 which is mainly expressed in the cone photoreceptors (Krizaj 2005).  
 
The mitochondrial uniporter plays a significant role in modulating Ca2+ signaling. It is found 
in the inner membrane of the mitochondria (Kirichok, Krapivinsky et al. 2004; Raffaello, De 
Stefani et al. 2012) and is a highly selective calcium ion channel which enables uptake of 
Ca2+ from the cytosol down the Ca2+ electrochemical gradient (Kirichok, Krapivinsky et al. 
2004). Ca2+ with calmodulin and in the cytosome are able to activate the mitochondrial 
uniporter.  
 
1.14.3. The “on” reactions 
Mechanisms which increase intracellular Ca2+ (shown as the “on” response in Fig 1.10) are 
mainly associated with the ER store and Ca2+ influx through plasma membrane. The release 
of Ca2+ from the ER store is mainly modulated by inositol 1,4,5-trisphosphate receptors (IP3R) 
and ryanodine receptors (RyR). Both of these are calcium selective channels. Also both 
enable Ca2+-induced Ca2+ release (CICR) which creates a positive feedback circuit to 
accelerate the increase in intracellular Ca2+ during Ca2+ signaling (Berridge 2009). In relation 
to the IP3R, phospholipase C (PLC) hydrolyzes PIP2 into Inositol 1,4,5-trisphosphate (IP3) 
and diacylglycerol (DAG). Both DAG and IP3 are second messengers. IP3 activates the ER 
store IP3Rs to release Ca2+ from the intracellular stores, whereas, the DAG (as well as Ca2+) 
activates Protein Kinase C. The RyR is another type of calcium-releasing channel which is 
found on the ER membrane. There are two different mechanisms regulating calcium release 
by the RyR: CICR and DICR (depletion induced Ca2+ release). There are three isoforms of 
RyR (RyR1-3), which can be activated by low cytoplasmic Ca2+concentration. In addition, 
Cyclic ADP-ribose (cADPR) can act as an endogenous stimulus at RyRs to induce Ca2+ 
release. In retinal cells, the RyR2 has been found was more widely expressed than other 
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RyRs (Shoshan-Barmatz, Zakar et al. 2007). In addition the IP3Rs and RyRs, a number of 
TRP channels are suggested to play a role in Ca2+ release from the intracellular store, for 
example TRPP2 (Nilius, Owsianik et al. 2007). 
 
At the plasma membrane Ca2+ influx is driven by the huge electrochemical gradient across 
the membrane, which is an effective way to increase the intracellular Ca2+. Ca2+enters the 
cells through different types of calcium channels, which include voltage-operated channels 
(VOCs), receptor-operated channels (ROCs), second messenger operated channels (SOCs) 
and store-operated channels (SOCs) (Figure 1.11). VOCs are expressed in most excitable 
cells; they are divided into two types, low-voltage-activated (also called T-type-transient) and 
high-voltage-activated (also called L-type-long-lasting). When depletion of the Ca2+ store 
occurs, SOCs will open and allow Ca2+ entry from the extracellular compartment to refill the 
ER (Nedergaard, Rodriguez et al. 2010). The transient receptor potential channels (TRP) are 
proposed to be an important kind of store-operated channel which can be activated by the 
depletion of ER Ca2+ store. ROCs respond to stimulation by neurotransmitters (Berridge, 
Bootman et al. 1998), include NMDA receptors (Berridge, Bootman et al. 2003) and P2X7 
receptors (McFadzean and Gibson 2002) which enable Na+ as well as Ca2+ to pass through 
them when the receptors are activated.  In relation to retinal neurons, the most important 
ROCs are NMDA and P2X receptors which respond to glutamate and ATP, respectively. 
SOCs regulate Ca2+ influx when the Ca2+ intracellular store is depleted. 
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Figure 1.11 Mechanisms of cytoplasmic Ca2+ increase (Berridge, Bootman et al. 1998). Ca2+ ion 
can enter cell through store-operated calcium channels (SOC) (1), receptor-operated calcium 
channels (ROC) (2) and voltage-operated calcium channels (VOC) (3). Ca2+ also can be released 
from the intracellular store, ER, when it is activated by Inositol 1,4,5-trisphosphate (Ins(1,4,5)P3) (4), 
and also ryanodine receptors (5). Overload of the mitochondria can trigger cell death. 
 
 
1.14.4. Calcium in retinal pathophysiology 
As well as signaling in processes essential for life, Ca2+ signaling is one of the critical 
messengers in mediating cell death (Berridge, Bootman et al. 1998; Berridge, Bootman et al. 
2003). Increasing intracellular Ca2+ beyond the physiological level, compromises neurons 
survival and results in neurons degeneration (Mattson 2007; Duncan, Goad et al. 2010). In 
the brain, excessive [Ca2+]i associates with cell death induced by ischemic insult (Li, Inoue et 
al. 2011). The retina is part of the CNS, therefore they share similar mechanisms of 
neurodegeneration (Crish and Calkins 2011).  
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Intracellular calcium is mainly derived from two sources: release from intracellular stores and 
influx through Ca2+-permeable channels in the membrane. Retinal ischemia initially results in 
ATP depletion and leads to membrane depolarization, which enhances influx of Ca2+ through 
VOCs and ROCs, as well as inhibition of ATP-dependent pumps (Osborne, Ugarte et al. 
1999; Osborne, Casson et al. 2004; Crish and Calkins 2011) (Figure 1.11). At the same time 
other ions, including Na+ and Cl- enter the cell along with H2O leading to cell swelling 
(Osborne, Casson et al. 2004; Bringmann, Uckermann et al. 2005). In addition, the increase 
in concentration of cytosolic Ca2+ has been shown to lead to activation of the mitochondrial 
uniporter and subsequent mitochondrial Ca2+overload, which in turn leads to apoptotic cell 
death (Raffaello, Stefani et al. 2012).  
 
Neuron cell membrane depolarization has effects on the glutamate releasing and uptake 
system causing glutamate to accumulate. Excessive glutamate will over-activate its receptors 
and further increase Ca2+ influx. These events will eventually cause intracellular Ca2+ 
overload and result in cell death through calcium-dependent or related pathways induced by 
[Ca2+]i elevation activates proteases, phosphatases, lipases and endonuclease (Szydlowska 
and Tymianski 2010). Their over-activity induced by Ca2+ will disrupt the structure of the 
plasma membrane and organelles (Szydlowska and Tymianski 2010; Momeni 2011), which 
further perpetuates the cellular damage. [Ca2+]i elevation also leads to an increase in 
generation of ROS (Carriedo, Sensi et al. 2000; Abramov, Scorziello et al. 2007; Feissner, 
Skalska et al. 2009), which mediates further damage.  
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Figure 1.12 Mechanisms of Ca2+disruption proposed to be involved in glaucomatous 
neurodegeneration (Crish and Calkins 2011). Multiple glaucomatous stressors disrupte 
Ca2+homeostasis and consequently increase oxidative stress and simulated calpain activity.  
 
 
1.15 Calpain 
The calpains are a family of Ca2+ dependent, cytoplasmic cysteine proteases. Calpain 
activation has been proposed to be one of the most significant events involved in RGC death 
in glaucoma (Paquet-Durand, Johnson et al. 2007; Huang, Fileta et al. 2010). Calpain was 
first described in the rat brain by Guroff G (1964). To date, there are known to be 15 calpain 
genes in human (Sorimachi and Ono 2012). Calpain-1 (µ-calpain) and calpain-2 (m-calpain) 
are ubiquitous and are the most extensively studied calpain isoforms. They have similar 
characteristics but are activated by different Ca2+ concentration, micro-molar and milli-molar 
cytoplasmic Ca2+ respectively (Perrin and Huttenlocher 2002).  
 
1.15.1. Calpain activation 
Calpain has a critical role in physiological processes, such as signal transduction and gene 
transcription (Goll, Thompson et al. 2003). In transgenic mice knocking out calpain-1 and 
calpain-2, is embryo lethal (Arthur, Elce et al. 2000). Calpain-3 is a muscle-specific calpain, 
and deficiency of calpain 3 results in pathological changes related to muscular dystrophy 
(Topaloǧlu, Dinçer et al. 1997; Richard, Roudaut et al. 2000). Uncontrolled calpain activation 
can lead to neuronal degeneration when [Ca2+]i has become pathologically elevated, which 
leads to cell death through apoptosis or necrotic mechanisms (Huang and Wang 2001; Artal-
Sanz and Tavernarakis 2005; Azuma and Shearer 2008).  
 
 
 
43 
Calpain activation is one of the significant event during cell apoptosis and necrosis (Perrin 
and Huttenlocher 2002). The most extensively studied consequence of calpain activation is 
proteolysis of cytoskeletal proteins. There are over 30 cytoskeletal proteins vulnerable to 
calpain activation (Nemova, Lysenko et al. 2010), including alpha-spectrin, tubulin and all 
three members of neurofilament family (Goll, Thompson et al. 2003). Uncontrolled calpain 
activity also damages Ca2+ channels and receptors of the plasma membrane and organelles 
(Momeni 2011), for example RyR (Rardon, Cefali et al. 1990) and inositol 1, 4, 5 
triphosphate receptor (Magnusson, Haug et al. 1993). 
 
Calpain activity can be regulated by several factors. The major regulating factor is 
cytoplasmic Ca2+ concentration and proteolysis is stimulated as the intracellular concentration 
of Ca2+ rises. The calcium requirement for half maximal activity of calpain-1 and calpain-2 is 
3–50µM and 400–800µM, respectively (Goll, Thompson et al. 2003). Under normal 
condition, calpain activity is modulated by calpastatin, which is an endogenous and specific 
inhibitor of calpain (Goll, Thompson et al. 2003). This inhibition will be removed when 
intracellular Ca2+ becomes overloaded. Furthermore, calpastatin is degraded by caspase-3 and 
possibly as also by calpain itself (Orrenius, Zhivotovsky et al. 2003). Calpain also undergoes 
autolysis, which decreases the Ca2+ requirement for activation. Calpain activation has been 
shown in relation to many human diseases, for example stroke and neurodegeneration 
(calpain-1 and 2) (Rami 2003), muscular dystrophy (calpain-3) (Topaloǧlu, Dinçer et al. 1997; 
Huang and Wang 2001; Azuma and Shearer 2008), and cataract (calpain-1 and 2) (Huang and 
Wang 2001).  
 
1.15.2. Calpain inhibitors 
The most common way to identify the involvement of calpain in models of disease is by use 
of calpain inhibitors. The addition of a calpain inhibitor, MDL 28170, in cerebral ischemia 
prevented infarct formation in rat (Markgraf, Velayo et al. 1998). In addition, MDL 28170 
significantly protected cardiac function from injury caused by Ca2+ overload (Bi, Jin et al. 
2012). Calpain inhibition was also shown to slow down cataract development in various 
models (Biswas, Harris et al. 2004; Morton, Lee et al. 2013).  
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1.15.3. Calpain activitation in retina 
Calpain-1 and 2 are both expressed in the rat retina, although the mRNA for calpain-2 was 12 
times higher than that of calpain-1 in rat retina (Tamada, Nakajima et al. 2005). Furthermore, 
calpain-1 was found to be expressed in relatively high amounts in RGC bodies in the rabbit 
retina (Croall and Demartino 1991). In addition to these two calpains, a further calpain 
isoform has been found in the rat retina, Rt88. This is a retina-specific calpain, which is a 
splice variant of calpain-3 (Azuma, Fukiage et al. 2000).  
 
Loss of Ca2+ homeostasis is regarded as an important factor in RGC loss in glaucoma and 
there is increasing evidence to suggest that calpain activation plays an important role in the 
glaucoma (Azuma and Shearer 2008). For example, in a model using retina ischemia-
reperfusion injury in rat, the calpain inhibitor SJA6017 was found to reduce RGC loss 
(Sakamoto, Nakajima et al. 2000). Also, in an experimental model of glaucoma with elevated 
IOP, calpain was be activated and was involved in mediation of retinal cell death (Nakajima, 
David et al. 2006; Huang, Fileta et al. 2010).  
 
1.16 Aim of this thesis 
The aim of this research was to develop a novel retinal planar sectioning technique to 
determine gene profiles in the retina and specifically in the retinal ganglion cell layer and to 
apply the information derived to investigation of Ca2+ dysregulation in the human retina in 
relation to glaucoma.  A planar cryosectioning technique which separated RGCL from the 
retina was successfully developed. Using this technique together with gene array technology, 
the transcriptome of human RGCs was investigated. In addition the mRNA distribution for 
selected Ca2+-signaling related proteins was determined in the human retina. Furthermore, the 
role of selected Ca2+-signaling related proteins in retina ischemia induced RGC death were 
assessed using HORCs model.  
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Chapter 2 
Materials and Methods 
 
2.1 Materials 
2.1.1 Human eye tissue 
Human eyes were obtained from the East Anglian Eyebank (Norfolk & Norwich University 
Hospital, Norwich, UK) with ethical approval and under the tenets of the Declaration of 
Helsinki for human research.  Eyes were donated for corneal transplant. Following removal 
of the cornea, globes were stored in Eagle’s minimum essential medium (EMEM) (Sigma-
Aldrich, Pool, UK) supplemented with 50 µg/ml gentamicin (Sigma-Aldrich, Poole, UK) and 
10 µg/ml antibiotic/antimycotic solution (10,000 units/ml penicilin G, 10,000 µg/ml 
streptomycin sulphate and 25µg/ml amphotericin B) (Invitrogen, Paisley, UK). The retinal 
tissue was used within 24 hours post-mortem. Donor information included age, gender, cause 
and time of death, past ophthalmic history and medical history including current medication. 
In the research presented in this thesis 66 pairs of donor eyes were used with an age range of 
37- 92. All the eyes used in this research were without retinal disease.   
 
2.1.2 Eye dissections 
Using sterile technique, the lens was removed from the globe by other group members. In 
order to dissect the retina, an incision of about 0.5 cm was made at the edge of the sclera. A 
circular scleral incision was cut around the edge of eyecup. The retina was dissected 
circumferentially just below the ora serrata. Following this, the neural retina was dissociated 
carefully from the RPE except at the optic nerve head. Using sharp scissors, the retina was 
removed from the eyecup by cutting around the optic nerve head. The neural retina was 
placed in a sterile cell culture dish and the vitreous humour removed. Due to the 
hemispherical shape, about four nicks of approximately 0.5 cm were made in order to allow 
the retina to flatten, before further samples were removed. 
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2.2 Planar section process 
2.2.1 Preparation of macular samples for planar Cryo-sectioning 
From each retina, a sample (4x4 mm) was taken from the macular region (Figure 2.1) using a 
surgical knife. This was identified by the yellow pigment of the macula lutea, and the 
position between the superior and inferior temporal vessels. Before mounting the sample, a 
cryo-sectioning block mould was pre-prepared in the following way. Optimal cutting 
temperature (OCT) medium (SAKURA, Leicestershire, UK) was placed on the surface of the 
cold block. Once frozen a flat surface was cut using Hacker Bright OTF5000/LS-003 cryostat 
(Bright Instruments, Huntingdon, UK). The sample was carefully floated onto a flat piece of 
filter paper with the photoreceptor cell layer uppermost. Excess fluid was removed by 
blotting with filter paper and the sample was placed, filter paper downwards, onto the pre-
prepared block. When the sample had frozen, fresh OCT medium was poured on top and 
allowed to freeze. Mounted samples were stored at -80⁰C until required. 
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Figure 2.1 (A) Fundus image taken in vivo with an ophthalmoscope. The position of the fovea is 
indicated. B, Equivalent image of human retina following dissection, showing the position of the foveal 
sample.  
 
 
2.2.2 Retinal planar cryo-sectioning 
The pre-prepared macula sample was mounted in the cryo-sectioner and samples were 
sectioned in the horizontal plane. Surplus frozen OCT medium was removed by cutting 
sections until the sample was revealed. Sections (20 µm) were then placed on glass slides and 
examined for cells under the microscope. Slices containing retinal tissue were collected 
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serially and individually in pre-cooled, labeled Eppendorf tubes and stored at -80 ⁰C until 
they were processed for RNA extraction. 
 
2.3 Quantitative real-time polymerase chain reaction (QRT-PCR) 
2.3.1 RNA extraction 
RNA extraction from retinal samples was carried out using the Qiagen Rneasy Micro Kit 
(Qiagen, Crawley, UK). Kits were used according to their manufacturer’s instructions. All the 
reactions were performed at room temperature, including centrifugation (Fisher Scientific, 
Loughborough, UK) (set at 16 ⁰C). The samples were incubated in RLT lysis buffer which 
contained 10 µl/ml β-Mercaptoethanol (Sigma-Aldrich, Poole, UK) and aspirated 5 times 
through a 20-gauge needle (0.9 mm) to homogenise the tissue. The homogenate was then 
centrifuged at 13,000 rpm for 3 minutes and the supernatant collected. 70% ethanol was then 
added to the supernatant. Each sample was transferred to an RNeasy column and centrifuged 
for 15 seconds at 13,000 rpm. The flow through was discarded. RW1 wash buffer was added 
to the column and centrifuged for 15 seconds at 13,000 rpm and the flow through again 
discarded. Then DNase solution (Qiagen, Crawly, UK) was then added to the column and 
incubated for 15 minutes at room temperature to remove any DNA. The column was then 
washed with buffer RW1 and centrifuged for 15 seconds at 13,000 rpm and the flow through 
discarded. The column was transferred to a new collection tube. An 80% ethanol/20% RPE 
buffer (Qiagen, Crawly, UK) was added to the column and centrifuged, and the flow through 
discarded. In order to dry the column, 80% ethanol was added and centrifuged at 13,000rpm 
for 2 minutes. The column was transferred to a new 2 ml collection tube and the column was 
centrifuged at 13,000 rpm for 5 minutes to dry spin column membrane, to ensure no ethanol 
would be eluted later. Finally, the column was transferred to a 1.5 ml collection tube. 12 µl 
RNase free water was added to the column membrane and incubated for 1 minute, then 
centrifuged for 1 minute at 13,000 rpm to elute the RNA. The RNA was stored at -80 ⁰C. 
 
2.3.2 First strand cDNA synthesis 
The concentration of RNA was measured using a Nanodrop ND-1000 spectrophotometer 
(NanoDrop Techologies, Wilmington, USA). The sample was then diluted with RNase free 
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water to give a concentration of 30-100 ng in10µl. Random primers (1 µl) (Invitrogen, 
Paisley, UK) and deoxyribonucleoside triphosphate (dNTP) Mix (consisting of equal 
concentration of dATP, dGTP, dTTP, dCTP) (1 µl)  (Bioline, London, UK) were then added 
to the RNA sample (10 µl) to give a total volume of 12 µl. The sample was heated to 65 ⁰C 
for 5 minutes using a Thermocycler DNA engine (PTC-200, MJ Research, Minnesota, USA). 
After this, the sample was chilled rapidly on ice. 4 µl of 5X First-Strand Buffer (Invitrogen, 
Paisley, UK), 2 µl of 0.1 M dithiothreitol (DTT) (Invitrogen, Paisley, UK) and 1 µl of RNase 
inhibitor (Invitrogen, Paisley, UK) were then added to the sample, which was then incubated 
at 25 ⁰C for 10 minutes and 42 ⁰C for 2 minutes. Following this, 1 µl of the reverse 
transcriptase enzyme SuperscriptTM II (Invitrogen, Paisley, UK), was added to the sample and 
incubated at 42 ⁰C for 50 minutes and 70 ⁰C for 15 minutes to synthesise the cDNA. cDNA 
was then stored at -20 ⁰C until use. 
 
2.3.3 Quantitive real-time polymerase chain reation (QRT-PCR) 
TaqmanTMQRT-PCR is an accurate method to quantify the expression levels of genes of 
interest. The specific primers target and amplify a region of the genes of interest from the 
cDNA. A specific probe binds to the gene of intrest. This is an oligonucleotide which has a 
fluorophore at the 5’- end and quencher at the 3’- end (Figure 2.2). The quencher quenches 
the fluorescence emission of the reporter fluorophore when they are in close proximity. As 
the amplification process occurs, the probe is released from the cDNA and exonuclease 
activity causes cleavage of the probe from the fluorophore and it is therefore no longer 
quenched. The fluorescence is detected by the system and accumulation of the fluorescent 
signal is proportional to the expression of the gene of interest. 
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Figure 2.2 The principle of Taqman™quantitative real-time PCR. When the probe is intact, the 
reporter fluorophore is quenched (A). During PCR, the double stranded DNA is heated and separated 
into single stranded and the probe hybridises with target gene sequences (B and C). As synthesis 
occurs, the reporter (R) is separated from the quencher (Q) (D). The fluorophore is measured cycle by 
cycle (E). The fluorescence is proportional to the amplification of the target gene.  Adapted from 
http://netclass.csu.edu.cn/JPKC2010/CSU/weishengwuxue/jiaoxueshijian/ 
 
 
TaqmanTM QRT-PCR used a 96-well plate. Wells were loaded with 5 ng cDNA (in 10 µl 
nuclease free water), 12.5 µl of Mastermix (Applied Biosystems, Warrington, UK), 1.25 µl 
primer/probe mix (Applied Biosystems, Warrington, UK) and 1.25 µl of nuclease free water 
to make a total volume of 25 µl and primer and probe concentration of 200 mM. All the 
primer and probe sets used are given in Table 2.1. The Mastermix contains all the 
components required for a PCR reaction: Taq polymerase, buffer, MgCl2, KCl, deoxy-
ribonucleoside triphosphate (dNTPs) and stabilizer. The PCR was performed using the ABI 
Prism 7700 Sequence Detection System (Applied biosystems, Warrigton, UK). The 
amplification step used was firstly 50 ⁰C for 2minutes then 95 ⁰C for 10 minutes, followed by 
40 cycles of 15 seconds at 95 ⁰C and 1 minute at 60 ⁰C for each amplification cycle.  
 
The cycle threshold (CT) value was determined using the 7500 Fast System Software 1.1.1 
(Applied Biosystems, Warrington, UK). This is the cycle number at which the signal 
becomes statistically greater than background and is proportional to the number of copies of 
mRNA for the target gene. Using a standard curve for the gene, the relative expression is 
calculated. The expression of the gene of interest in each section is calculated relative to the 
section with the highest expression. There was no control gene was used to analyze the data 
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of interesting genes, as the reason of there is multiple cell types through the retina and each of 
these cell types has different expression ability to the control genes.  
 
 
Table 2.1 The probes/primers used for TaqmanTM QRT-PCR. 
Probes  
& 
primers 
Official full name Part number Supplier 
THY-1 Thy-1 cell surface antigen Hs00174816-m1 Applied Biosystems, 
Warrington, UK 
POU4F1 POU class 4 homeobox 1 Hs00366711-m1 Applied Biosystems, 
Warrington, UK 
RCVRN Recoverin Hs00610056-m1 Applied Biosystems, 
Warrington, UK 
P2X7 Purinergic receptor P2X, ligand-gated 
ion channel, 7 
Hs00175721-m1 Applied Biosystems, 
Warrington, UK 
TRPC-1 Transient receptor potential cation 
channel, subfamily C, member 1 
Hs00608195-m1 Applied Biosystems, 
Warrington, UK 
TRPC-3 Transient receptor potential cation 
channel, subfamily C, member 3 
Hs00162985-m1 Applied Biosystems, 
Warrington, UK 
TRPM-2 Transient receptor potential cation 
channel, subfamily M, member 2 
Hs00268573-m1 Applied Biosystems, 
Warrington, UK 
TRPV-1 Transient receptor potential cation 
channel, subfamily V, member 1 
Hs00218912-m1 Applied Biosystems, 
Warrington, UK 
RBFOX3 RNA binding protein, fox-1 homolog 
(C. elegans) 3 
Hs00876928-m1 Applied Biosystems, 
Warrington, UK 
CHAT Choline O-acetyltransferase Hs00758143-m1 Applied Biosystems, 
Warrington, UK 
CALB1 Calbindin 1 Hs00191821-m1 Applied Biosystems, 
Warrington, UK  
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2.4 Illumina gene array analysis 
For this array analysis the retina from donors were used. The detail of these donors are given 
in Table 2.2. Gene array analysis was performed by Source BioScience (UK). The 
Bioconductor package (http://www.bioconductor.org) in R (http://www.r-project.org) was 
used to process array data obtained from RGC and MAC samples. First of all, data was 
background corrected, quantile normalized and variance stabilized. Then, a hierarchical 
clustering plot was constructed to check that samples from RGC and MAC grouped together. 
Then, in order to compensate for false positive data, only genes presented in over 50% of 
each group were retained (McClintick and Edenberg 2006). The fold change of each gene 
was calculated, that is, the difference in average expression level of given gene between RGC 
and MAC. 
 
To obtain biologically meaningful results, p values for each gene were calculated using an 
extension of the empirical Bayes moderated t-statistic known as TREAT (McCarthy et al., 
2009). This statistic allows formal testing of the hypothesis that a gene is more differentially 
expressed than a given fold change (FC). Since multiple comparisons are performed, the p-
value adjusted for multiple testing (q-value) is computed to control the expected likelihood of 
falsely identifying a gene as differentially expressed; this is known as the false discovery rate 
(FDR). The most “up-regulated genes” are therefore those most highly expressed in the RGC 
layer compared to the entire macula. The most “down-regulated genes” are those expressed 
most highly in the entire macula compared to the RGCL.   
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Table	  2.2	  Donor	  information	  for	  retina	  samples	  used	  in	  the	  gene	  array	  experiments.	  Information	  is	  given	  as	  
reported	  on	  the	  Research	  Tissue	  Donation	  Form. 
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2.5 Histological labeling and Immunolabelling 
2.5.1 Paraffin-embedded sections 
The macula sample was fixed in 4% formaldehyde (Sigma-Aldrich, Poole, UK) in Phosphate 
Buffered Saline (PBS) (Thermo Scientific, Basingstoke, UK) solution for 24h at 4 ⁰C. The 
tissue was then dehydrated through a graded ethanol (30%, 50%, 70%, 90% and 100% (v/v) 
(ethanol/water), at 4 ⁰C with 30 minutes for each step. Following this, the sample was 
transferred to 50% xylene/ethanol (v/v) for 30 minutes at room temperature (RT). The 
solution was then replaced with 100% xylene for 30 minutes at RT. The tissue was now ready 
to embed. It was placed in a suitable mould and incubated in 50% then 100% wax (diluted in 
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xylene) in the oven at 60 ⁰C for 60 minutes for each step. Finally, the sample was taken out 
from the oven and allowed to cool before sectioning. The sample was sectioned into 5 µm 
slices and mounted on glass slides. The slide was heated at 60 ⁰C heater until dry to allow the 
section to adhere to the slide. 
 
2.5.2 Hematoxylin-eosin (H&E) staining 
To remove the wax, the slide was dipped into 100% xylene for 5 minutes, and then graded 
ethanol from 100%, 90%, 70%, 50%, and 30% to distilled water, with 1 minute for each step. 
Following this, the slide was put into Hematoxylin (Sigma-Aldrich, Poole, UK) solution for 5 
minutes to stain the cell nuclei. The slide was washed with distilled water, before putting the 
slide into 1 % acid ethanol solution (for differentiation) for 1 minute. After that, the slide was 
washed again with distilled water then placed into 0.25% Eosin (Sigma-Aldrich, Poole, UK) 
solution for 3 minutes to stain the cytoplasm. To dehydrate the sample, the slide was dipped 
into graded ethanol from distilled water, 30%, 50%, 70%, 90% and 100% (V/V) (ethanol/ 
distilled water) 1 minute for each step, and then the slide was transferred to 100% xylene to 
improve cell transparency. Finally the slide was mounted in Hydromount medium (National 
Diagnostics Ltd, Hull, UK) sealed using a coverslip (VWR International, Lutterworth, UK), 
and left to dry overnight. Images were obtained using Nikon TE200 Eclipse Microscope 
(Nickon industries, Tokyo, Japan) with Nikon Coolpix 950 digital camera and MDC lens 
(Nickon industries, Tokyo, Japan). 
 
2.5.3 Immunohistochemistry of paraffin-embedded sections 
Slides were immersed in 100% xylene for 5 minutes to remove the wax, then dehydrated in 
graded ETOH (100%, 90% and 70%) for 1 minute, before washing with distilled water for 2 
minutes.  
The sample was gently washed in PBS (10 minutes for 3 times) before permeabilization in 
blocking solution which contained 5% goat serum (Sigma-Aldrich, Poole, UK) and 0.2% 
Triton X100 (Sigma-Aldrich, Poole, UK) in PBS. Following this, the slide was washed three 
times in PBS. The primary antibody (Table 2.3) was diluted in blocking solution and 50 µl 
added per sample and incubated overnight at 4 ⁰C. 
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Table 2.3 The primary antibodies were used for immunohistochemistry of paraffin-embedded 
sections. 
Target 
protein 
Epitope Host 
species 
Dilution Supplier and Product code 
NeuN Vertebrate neuron-specific 
nuclear protein 
Mouse 1:200 MAB377, Millipore, 
Watford, UK 
  TRPM-2 Human transient receptor 
potential cation channel, 
subfamily M, member 2 
Rabbit 1:50 NB500-242, Novus 
Biologicals, Cambridge, UK 
AHNAK2 AHNAK nucleoprotein 2 Mouse 1:300 AB70053, Abacam 
!III-Tubulin  C-terminus of !III tubulin Mouse 1:2000 G7121, Promega 
THY-1 Thy 1.1 antigenic determinant Mouse 1:200 MAB1406, Millipore 
HSPA1 Heat shock 70kDa protein 1A/B Rabbit 1:50 10995-1-AP, Proteintech  
  
 
To remove the antibody, the slide was washed three times in PBS before adding 50 µl per 
sample of secondary antibody solution (Table 2.4), diluted 1:1000 and incubated for 2 hours 
in the dark at RT. The following steps were carried out in the dark. The slide was washed 3 
times in PBS to remove the extra secondary antibody, then 0.5 µg/ml of 4’,6-diamidino-2-
phenylindole dilactate (DAPI) (Invitrogen, Paisley,UK) solution in PBS was added to the 
slide, and incubated for 10 minutes at RT. Following the final three washes in PBS the slide 
was dried. A drop of Hydromount medium was pipetted onto each sample and a coverslip 
was placed over the section and sealed, then store at 4 ⁰C in the dark until required.  
 
Table 2.3 Secondary antibodies used for immunohistochemistry of paraffin-embedded 
sections. 
Secondary antibody Specificity  Species Dilution Supplier 
Alexafluor 488 Mouse Ig light chains Goat 1:1000 Invitrogen, Paisley, UK 
Alexafluor 568 Mouse Ig light chains Goat 1:1000 Invitrogen, Paisley, UK 
Alexafluor 568 Rabbit Ig light chains Goat 1:1000 Invitrogen, Paisley, UK 
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2.6 Systems to simulated retina ischemia in vitro 
2.6.1 Human organotypic retinal cultures (HORCs) dissection 
The neural retina was dissociated from the eye as described above and placed in a 60mm 
Petri dish (Corning, NY, USA) in 5 ml of warmed CO2-independent medium (Gibco-
invitrogen, Paisley UK). A 5-samples template (Figure 2.3) was used to ensure that para-
macular samples were taken from the same position of each retina. Previous research has 
shown that para-macular samples taken from these positions have an equivalent number of 
RGCs (Niyadurupola, Sidaway et al. 2011). The macula sample was removed first using a 
4mm diameter trephine (Biomedical Research Instruments, MD USA). 5 x 4 para-macular 
samples were then taken. Samples were cultured in 35 mm cell culture dishes (Corning, NY, 
USA) in serum free DMEM/F-12 medium supplemented with 50 µg/ml gentamycin and 292 
µg/ml L-glutamine (Gibco-invitrogen, Paisley, UK) at 35 °C, buffered to pH 7.4 with 5% 
CO2. 
 
 
 
 
  
 
  !"#$%" 
 
Figure 2.3 Template for the 5 para-macular samples. The macula region was removed first, and 
then used position the template to allow consistent positioning of the paramacular samples.  
 
 
2.6.2 Simulated ischemia (oxygen glucose deprivation, OGD) in HORCs 
HORCs to be exposed to the OGD protocol was placed in 2 ml of serum and glucose free 
Dulbecco’s modified Eagle medium (DMEM) (Gibco-Invitrogen, Paisley, UK) (with 50 
µg/ml gentamycin and 292 µg/ml L-glutamine). Following this, the dishes containing the 
HORCs were placed into a modular incubator chamber (Billups-Rothenburg, CA, USA) and 
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the chamber was gassed with 95% N2/5% CO2  for 10 minutes to deplete O2. The inlet and 
outlet pipes were then sealed and the chamber incubated at 35 °C for required time. 
Following the ischemia culture of OGD, the HORCs were then switched to pre-warmed 
serum free DMEM/HamF-12 medium (Gibco-Invitrogen, Paisley, UK) for a total of 24 hours 
in culture including simulated ischemic culture at 35 °C in a 95% O2/ 5% CO2 incubator. This 
is referred to as the reperfusion period. The control HORCs samples were processed the same 
operations, but however, they were cultured in serum free DMEM but with glucose (Gibco-
Invitrogen, Paisley, UK) with the same culture time as ischemia group, which was cultured at 
35 °C in the incubator with 95% O2 air /5% CO2 in the same incubator as the ischemia 
chamber. After the simulated ischemia this period, the HORCs were transferred back to 
serum free DMEM/HamF-12 containing glucose, referred as reperfusion period.  
 
2.6.3 Simulated Ischaemia with inhibitors 
N-(p-amylcinnamoyl)anthranilic acid (ACA) and calpain inhibitor III, MDL28170 
(carbobenzoxy-valylphenylalanial; Z-Val-Phe-CHO), were used and purchased from 
MerckMillipore (Watford, UK). There were some inhibitors were investigated with the 
stimulated ischemia HORCs in this thesis, they are ACA and MDL28170. Inhibitors were 
initially dissolved in DMSO to make a 20 mM stock solution. Inhibitor/DMSO was added to 
OGD or control medium to give a final concentration of 20 µM.  Media without inhibitor 
contained DMSO added to the same concentration as when the inhibitor was present (vehicle 
control). The inhibitor was present at both the OGD and reperfusion stages. 
 
2.7 Lactate dehydrogenase (LDH) assay 
LDH release is a measurement used to assess cell death. Cytosolic enzymes, including LDH, 
are released through damaged cell membrane into the cell culture medium, and measurement 
of LDH activity in the medium is therefore related to the number of damaged cells.  The 
biochemical basis of the assay is shown in Fig. 2.4. The HORC culture medium was collected 
and stored at 4 °C until used. The medium was centrifuged at maximum speed for 5 minutes. 
The Cytotoxicity Detection Kit (LDH) (Roche Products Limited, Welwyn Garden City, UK) 
was used according to the manufacturer’s instruction. The LDH kit contains 2 solutions, 
catalyst solution and dye solution. The reaction solution requires 1 part catalyst to 45 parts of 
dye solution. These were mixed together, and then were added to 100µl of medium in a 96-
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well plate. The plate was incubated in the dark at 37 °C for 10 minutes. The absorbance at 
490 nm was measured using a FLUOstar Omega (BMG-LABTECH, Aylesbury, UK).  
 
 
Figure 2.4 Principle of the LDH assay. LDH catalyses the conversion of lactate to pyruvate and 
during the reaction NAD+ is reduced to NADH. The NADH is then involved in a reaction catalyzed by 
diaphorase to generate a coloured formazan product. The formazan produced is therefore 
proportional to the amount of LDH in the culture medium. http://www.beyotime.com/c0016.html   
 
 
2.8 Cryosetioning of HORCs and Immunohistochemistry 
2.8.1 Transverse cryosectioning of HORCs 
HORCs were fixed in 4% formaldehyde for 24 hours, and then dehydrated in 30% sucrose 
(Fisher Scientific, Loughborough, UK) which dissolved in PBS for 24 hours. The samples 
were then placed into cryostat block cups filled with OCT medium and frozen on dry ice. 
They were stored at -80 °C. The retinal sample was cut into 13 µm slices by cryosectioning, 
and three pieces of slices from each sample were collected onto one slide (Sigma-Aldrich, 
Poole, UK). The slide was previously coated with 3’aminopropyl-triethoxyl silane (Sigma-
Aldrich, Poole, UK). The immunohistochemistry was carried out following the same 
processes as described in section 2.4.3, starting from first PBS washing step. 
 
2.8.2 Terminal deoxynucleotidyl transferase UTP nick end labeling (TUNEL) assay 
The TUNEL assay is a method to detected cellular apoptosis through labeling of the 
fragments of DNA nuclear generated as a result of the apoptotic process. One of the most 
significant characteristics of apoptosis is that double-stranded DNA is digested by 
endogenous endonucleases that cleave the DNA into fragments initiated by nicks in the DNA 
backbone. In the TUNEL assay, the exposed 3’-OH end combines with fluorescein-12-dUTP 
by the action of terminal deoxynucleotidyl transferase (TdT) (Figure 2.5). All the TUNEL 
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assay reagents were supplied by Promega Life Science DeadEnd™ Fluorimetric TUNEL 
System (Southampton, UK), and the kit was used according to the manufacturer’s 
instructions.  
 
 
Figure 2.5 Principle of the TUNEL assay. Image was adapted from 
http://www.invitrogen.com/etc/medialib/en/images/ics_organized/applications/cell_tissue_analysis/dat
a_diagram/560_wide.Par.90837.Image.559.231.1.s006323-Click-iT-Tunel-Assay-gif.gif 
 
 
 
The HORC sections were washed with PBS (5 minutes for 3 times). Following the wash, 
0.2% Triton X-100 in PBS solution was added to cover the retinal sections for 5min at room 
temperature to permeabilize the cell membrane. They were then treated with Equilibration 
Buffer for 10 minutes, then washed in PBS (5 minutes for 3 times). Following this, the 
sections were covered with 50 µl rTdT incubation buffer, which was made up from 
Equilibration Buffer, Nucleotide Mix and rTdT enzyme (ratio of 45:5:1, V/V/V) and 
incubated for 1 hour at 35 °C. This and subsequent incubations were carried out in the dark. 
The reaction was stopped by immersion of the slides in 2X standard saline citrate (SSC) for 
15 minutes. This was followed by PBS washes (5 minutes for 3 times). Cell nuclei were 
stained with DAPI diluted in PBS (1:1000, V/V) for 10min at RT. Three further PBS washes 
of each 5 minutes, removed the excess DAPI dye. The sections were then mounted in 
Hydromount medium. The sections were imaged using a Zeiss Axiovert 200M upright wide-
field fluorescent microscope (Zeiss, Welwyn Garden City, UK) at 10X magnification.  Image 
capture was via a CCD camera (Zeiss AxioCam, Welwyn Garden City, UK) using Zeiss 
Axiovision 4.7 software. 
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2.8.3 Quantification of retinal ganglion cell loss 
Retinal slices were labelled with NeuN antibody by immunohistochemistry to allow 
assessment of retinal ganglion cell number. 10 images of each HORC sample were taken at 
10X magnification using a Zeiss Axiovert 200M upright wide-field fluorescence microscope. 
For each image, the number of NeuN positive immunolabelled cells in 200 µm was counted 
from three different areas of each image. All the images were randomly assigned and counted 
by other members of the lab in a masked manner. A mean was calculated for each HORC 
from each image.  In sections that had also been TUNEL labeled, the number of TUNEL-
positive NeuN-labelled cells was also counted. 
 
2.9 QRT-PCR of HORCs 
The process of QRT-PCR of HORCs was same as the method was given in the Section 2.3, 
RNA extraction, First strand cDNA synthesis and finally detected THY-1 expression using 
7500 Fast System Software 1.1.1. The only exception was RNA extraction of HORCs.  
HORCs were extracted RNA using Qiagen Rneasy Micro Kit (Qiagen, Crawley, UK), and 
followed its manufacturer’s instructions. After the QRT-PCR was determined, the data was 
normalised using two housekeping genes, TOP-1 and CYC-1, to improve data validity. These 
two housekeeping genes have been found previously in the lab that they were the most stable 
genes of HORCs under the stimulated ischemia and were chosen for data normalization 
(using the GeNorm programme) (Niyadurupola, Sidaway et al. 2011). The geometric mean of 
expression of these 2 genes was therefore used to normalize expression data in HORCs 
experiments.   
 
2.10 Kinase signaling 
2.10.1 Protein extraction 
All the end of the HORCs experiments, explants were transferred to 1.5 ml Eppendorf tubes, 
frozen immediately in liquid nitrogen and stored at -80 °C. To lyse and extract the protein 
from the HORCs, cell lysis buffer was used of the following composition: 10 µl/ml EDTA 
solution (0.5 mM) (Thermo Scientific, Cramlington, UK), 10 µl/ml Protease inhibitor 
(Thermo Scientific, Cramlington, UK) and 10 µl/ml phosphatase inhibitor diluted in M-PER 
solution (which contains 25 mM bicine buffer at pH 7.6) (Thermo Scientific, Cramlington, 
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UK). 200 µl of lysis buffer was added to the sample and homogenized. The samples were 
then incubated in the fridge for 30 minutes before being spun for 10min at 13000 rpm. The 
supernatant was collected and stored at -80 °C until required. 
 
2.10.2 Bicinchoninic acid (BCA) Protein Assay 
The bicinchoninic acid (BCA) protein assay (Thermo scientific, Cramlington, UK) was used 
to measured protein concentration from HORC samples according to the manufacturer’s 
instructions. In this assay, the original colour appears green due to the present of Cu2+. The 
Cu2+ is reduced to Cu+ by the protein, which then binds with bicichoninic acid to produce a 
purple coloured compound. This can be measured by the absorbance at 562 nm. The 
absorbance increase at 562 nm is proportional to protein concentration. 10 µl samples were 
loaded into the 96 well plate in triplicate. The BCA assay reagent solution was made up with 
1 part Cupric Sulphate solution and 45 parts bicichoninic acid solution. 100 µl was added to 
the protein samples, and incubated at 37 °C for 30 minutes. The plate was read using a plate 
reader (Victor, EG & G Wallace Instruments, Cambridge, UK). The protein concentration 
could be quantified using a calibration curve (BSA: 0-2000 ng/µl).  
 
2.10.3 Polyacrylamide gel electrophoresis 
Protein extract was diluted in distilled water to obtain equal volume of protein solution up to 
4.5 µl which contained equal quantity of protein (1 µg), NuPAGE® LDS sample buffer (4.5 
ul) (Invitrogen, Paisley, UK) and 1 ul NuPAGE® sample reducing agent (10X) (Invitrogen, 
Paisley, UK) were added to the sample, which made a total volume of 10 µl. The samples 
were heated at 100 °C for 5 minutes.  
 
Samples were run using the NuPAGE® system from Invitrogen (Invitrogen, Paisley, UK). 
NuPAGE® Novex® 4-12% Bis-Tris gels were placed into the XCell SureLock™ Mini-Cell. 
NuPAGE® MOPS SDS running buffer was added. The protein samples (10 µl) and 
MagicMark™ XP Western protein standard (Invitrogen, Paisley, UK) were loaded onto the 
gel. The gel was run at 200 V for 50 minutes in the cold room (7 °C).  
 
For transferring the protein, the gel was removed from the cell and placed into a square Petri 
dish with NuPAGE® transfer buffer. Polyvinylidene fluoride (PVDF) membrane (Perkin 
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Elmer, Cambridgeshire, UK) was cut to the same size as the gel and immersed in 100% 
methanol. The gel and PVDF were then sandwiched between two pieces of thick filter paper 
that had been immersed previously in the NuPAGE® transfer buffer. Then the gel was placed 
into the transfer blotter, SureLock™ Mini-Cell (Invitrogen, Paisley, UK), with gel closest to 
the cathode. The inside of the chamber was filled with transfer buffer and the outside filled 
with distilled water. The proteins were transferred at 30 V for 60 minutes at room 
temperature.  
 
2.10.4 Western blot – protein detection 
The membrane was placed into a square Petri dish and incubated for 1 hour at room 
temperature in blocking solution of following composition: 0.1% Tween®-20 (Fisher 
Scientific, Loughborough, UK) with 5% milk powder in PBS (PBS-T). The primary antibody 
was diluted with PBS-T at the required concentration (Table 2.5). The membrane was then 
incubated in primary antibody solution for 2 hours at room temperature or overnight at 4°C. 
The primary antibody was removed and the membrane washed three times for 15 minutes in 
PBS-T to remove unbound antibody. Following this, the membrane was incubated, with 
shaking, with secondary antibody (Table 2.6) diluted at 1:1250 in PBS-T for 2 hours at room 
temperature. The secondary antibody was then removed and the membrane washed (15 
minutes for 2 times) in PBS-T, followed by one wash with PBS-T without milk powder for 
10 minutes at room temperature. Bound antibody was detected using ECL reagent (GE 
Healthcare, Buckinghamshire, UK) according the manufacturer’s instructions. ECL reagent 
was applied to the membrane and incubated for 5 minutes at room temperature. The 
membrane was placed into a film cassette (GE Healthcare, Buckinghamshire, UK). 
 
In the dark room, the ECL reagent was removed and chemiluminescence film paper (GE 
Healthcare, Buckinghamshire, UK) was placed on the membrane in the film cassette. It was 
then removed and developed using GBX developer solution (Kodak,GBX developer) until 
bands appeared. The developing action was ended by the stop solution (Photosol SB80, 
Basildon, UK), and then fixed in the fixative (Ilford Imaging, Mobberley, UK) until the 
background of film was invisible. Finally, film paper was rinsed by tap water and air-dried. 
The bands were scanned (HP Deskjet 3050), and their band intensity quantified using Image-
J (http://rsbweb.nih.gov/ij/).  
 
 
 
62 
Table 2.5 Antibodies were used for Western blot. 
Antibody Dilution and Resource  Supplier and product code 
!-Fodrin (1st antibody) 1:1000, Mouse Enzo Life Sciences, Exeter?UK 
Calpain 2 (1st antibody) 1:1000, Rabbit  Abcam, Cambridge, UK 
"-actin    (1st antibody) 1:2000, Rabbit Cell Signaling Technology, 
Danvers, UK 
Vimentin  (1st antibody) 1:1000, Mouse Sigma, Dorset, UK 
Anti-mouse IgG HRP Sheep 
conjugate (2nd antibody) 
1:1250 GE Healthcare, Buckinghamshire, 
UK 
  
Anti-rabbit IgG HRP 
Donkey conjugate (2nd 
antibody) 
1:1250 GE Healthcare, Buckinghamshire, 
UK 
   
 
 
2.11 Data analysis 
Data is expressed as the mean ± standard error of the mean (S.E.M.) for at least 4 
independent experiments. Student’s t-test was used to evaluate the significance of differences 
between two groups.  A probability of p≤0.05 was taken as significant. 
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Chapter 3 
A novel planar sectioning technique for profiling of the human 
retina 
               
3.1 Introduction: 
The human retina is a highly complex tissue and contains 10 distinct layers and multiple cell 
types. According to their morphological and physiological characteristics, there are 5 classes 
of neuronal cell in the retina: photoreceptor cell, horizontal cell, bipolar cell, amacrine cell 
and retinal ganglion cells. There are also several non-neuronal cell types, the major one being 
Müller cells (Bringmann, Pannicke et al. 2009). Identification of regional expression in the 
retinal layers is studied largely by immunohistochemistry, but this is reliant on good quality 
antibodies being available. This chapter describes development and characterization of a 
method to section the human retina in order that mRNA profiles across the retina can be 
determined.   
Previous reports have demonstrated that in glaucoma RGCs are severely affected and the 
thickness of the RGCL is greatly decreased compared with other retinal neuronal cells and 
retinal nuclear layers which show minimal changes in both experimental glaucoma and 
glaucoma patients (Kendell, Quigley et al. 1995; Osborne, Ugarte et al. 1999; Kielczewski, 
Pease et al. 2005). It has been identified that the death of RGCs in glaucoma seems to be by 
an apoptotic mechanism (Quigley, Nickells et al. 1995; Kerrigan, Zack et al. 1997). 
Therefore, in order to investigate the signaling pathways and changes in gene regulation that 
are involved in glaucoma, it is important that the genes expressed in human RGCs are 
identified. The techniques developed will enable the expression in the RGC layer to be 
studied. 
Recently, several groups have investigated the RGC gene expression profiles of normal 
RGCs and also in the animal models of glaucoma (Ahmed, Brown et al. 2004; Ivanov, 
Dvoriantchikova et al. 2006; Kim, Kuehn et al. 2006; Guo, Cepurna et al. 2010). Expression 
in human RGCL has also recently been investigated (Kim, Kuehn et al. 2006). Typically two 
ways have been used to isolate the cells: immuno-panning from mixed retinal cells (Ivanov, 
 
 
 
64 
Dvoriantchikova et al. 2005; Hong, Iizuka et al. 2012; Siegert, Cabuy et al. 2012) and laser 
capture microdissection (LCM) (Kim, Kuehn et al. 2006; Guo, Cepurna et al. 2010).  
Immuno-panning is a valid method to isolate large numbers of pure RGCs, which gives 90-
99.5% purification of RGCs (Barres, Silverstein et al. 1988; Hong, Iizuka et al. 2012). The 
method uses an enzyme, such as papain, to digest the connections between the RGCs and 
other retinal cells, followed by purification of the RGCs by binding to the Thy-1 antibody 
that has usually been immobilised on a Petri dish. Cells can be used directly or plated in order 
to gain cultures of RGCs. The survival rate has been found to be around 85% 3h after plating 
(Meyer-Franke, Kaplan et al. 1995). Protocols improve cell viability and prolong cell life 
have also been developed, for example adding brain derived neurotropic factors or other 
growth factors (Ma and Taylor 2010; Zhang, Liu et al. 2010). These methods, however, have 
only been used for rodent retinas. Attempts have been made in our lab to use these techniques 
in human retina, but have not been successful. 
LCM is a powerful and potentially precise way to capture cells of interest by removing the 
rest of retinal cells under the microscope. However, the close morphological similarity and 
proximity to RGCs make it potentially difficult to distinguish displaced amacrine cells from 
RGCs. Therefore previous studies using this technique in retina have mainly taken the entire 
RGC layer rather than isolating the RGCs. Even when the entire RGCL is taken, experiments 
using these techniques remain very time consuming. Further to this, they only yield low 
quantities of mRNA. Therefore, an alternative method was developed in this study.  
The aim of this study was to develop novel techniques to obtain large quantities of high 
quality mRNA from planar retinal sections that would enable analysis of gene expression 
profiles in the human RGCL. 
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3.2 Results: 
3.2.1 Histological investigation of the human retina layer from the macular region to the 
periphery retina 
Preliminary experiments looked at thickness of the RGCL in the human retina. The retina 
was stained with Haemotoxylin and Eosin (H&E), to look at histological characteristics of the 
macular, paramacular and peripheral human retina. In terms of overall morphology, the 
macula region was thickest, decreasing in thickness out to the peripheral retina (Figure 3.1). 
The retinal ganglion cell layer in the macular region was several cells thick and was the 
thickest of the retinal nuclear layers (Figure3.1A). Ganglion cell number and thickness 
decreased from the macular to the para-macular region (Figure 3.1B). There were only a few 
ganglion cells localized in the RGCL in the peripheral region (Figure 3.C). Other two nuclear 
layers were of a similar thickness in the macular and para-macular, but not in peripheral 
retina. Furthermore, the three retinal nuclear layers and plexiform layers could be clearly 
determined in the macular and para-macular regions, but were difficult to identify in the 
peripheral retina. Note that these sections did not contain photoreceptor outer segments, 
which have been shed beyond the outer limiting membrane.  
Overall these images show that the morphology of the human retina is well maintained in the 
samples derived from the post mortem donor eyes. They also confirmed that the RGCL is the 
thickest in the macular region of healthy human retina. Therefore, this was selected for 
further experiments to develop the sectioning technique since in this research we are most 
interested in determining expression in human RGCs.  
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Figure 3.1 H&E staining of human retina. A, macular region; B, para-macular region; C, peripheral 
region. RGL = retinal ganglion cell layer, INL = inner nuclear layer, ONL = outer nuclear layer. 
 
 
3.2.2 RNA was extracted from the retina planar sections. 
Using the macular region, techniques were developed to section the retina in order to obtain 
samples from the retinal cell layers that could be used for mRNA profiling. This involved 
ensuring that the retina was flat so that the sample of each section was from the same layer of 
retina. In order to make it as flat as possible, frozen OCT medium on a metal block mould 
was cut using a cryosectioning machine. This provided the flat surface on which to mount the 
retina. The sample was carefully floated onto a piece of filter paper. Following this, the filter 
paper with macular sample was placed onto that flattened OCT surface, and the sample 
covered by liquid OCT medium prior to freezing immediately on dry ice. The macular 
sample was then ready for cryosectioning. The thickness of each section was set at 20µm. 
Macular planar sections were collected serially into respective Eppendorfs. For each macular 
sample, approximately 21 sections were obtained. 
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The serial retina planar sections were collected and extracted RNA. High yields of RNA were 
got from each 20 µm section, particular in the inner retina part (Figure 3.2). After the RNA 
extraction, over 10µl of solution was obtained from each section, which contained 
approximately 5-40 ng/ul. The highest concentrations were obtained from the inner retina. 
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Figure 3.2 RNA level through retina planar section. Serial cryosections were taken and extracted 
and measured by Nanodrop. Mean ± standard error of the mean (S.E.M), n=5. 
 
 
3.2.3 Expression profiles of retinal cell markers. 
Gene expression of selected retinal cell markers was measured using quantitative PCR 
(Figure 3.3 and Figure 3.4). Markers used were recoverin (RCVRN) for 
photoreceptors(Dizhoor, Ray et al. 1991), calbindin (CALB) for horizontal cells (Nakhai, Sel 
et al. 2007), choline acetyltransferase (CHAT) for amacrine cells (Haverkamp and Wassle 
2000) and Thy-1 (Barnstable and Drager 1984), NeuN (RBFOX3) and (Buckingham, Inman 
et al. 2008) and Brn3a (POU4F1) (Nadal-Nicolas, Jimenez-Lopez et al. 2009) for retinal 
ganglion cells. RCVRN expression was highest in the outermost sections and almost absent 
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from the inner RGC layer. Given this distinct profile, RCVRN was used to line up the 
sections from different retinal samples: samples were aligned at the section where RCVRN 
expression started to increase. The peaks for CALB and CHAT expression corresponded 
closely with the positions of horizontal and amacrine cells respectively. Furthermore, the 
known RGC markers Brn3a, Thy-1 and NeuN were most highly expressed in the innermost 
sections corresponding to the RGC layer (Figure.3.4). Expression profiles of the retinal cell 
markers were therefore highly consistent with their expected positions in the retina (Figure 
3.3 A and C). 
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Figure 3.3 The expression profile of retinal ganglion cell markers in human retina. (A) Diagram 
showing the different cells of the retina. Adapted 
fromhttp://php.med.unsw.edu.au/embryology/index.php?title=File:Retina-layers-diagram.jpg. (B) 
Serial cryosections of the retina were taken from photoreceptor cell layer to the ganglion cell layer. (C) 
Gene expression of RCVRN, CALB, CHAT and THY-1 were measured by quantitative PCR and 
normalised to the highest expression. Mean ± standard error of the mean (S.E.M), n=8. 
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Figure 3.4 The expression profile of RGC markers in human retina. Serial cryosections were 
taken and gene expression was measured by QRT-PCR. Mean ± standard error of the mean (S.E.M), 
n=8. 
 
 
To confirm the mRNA profiles, immunohistochemistry was carried out on macular transverse 
sections. NeuN and Thy-1 are both reliable retinal ganglion cell markers; they were therefore 
used to immune-label RGCs in the human macular sections. Recoverin is specific marker of 
both cones and rods photoreceptor cells; this was used to stain photoreceptor cells. It can be 
seen that NeuN and Thy-1 antibodies stain cells in the RGCL (Figure 3.5).  It is notable that 
only a few cells displaced RGCs are seen in the inner nuclear layer. RCVRN presented an 
excellent immunoreaction in the outer retina (including OPL, ONL and possibly as well as 
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outer segment layer) (Figure 3.6). Therefore, the immunostaining presented the consistent 
patterns as their mRNA distribution in the retina macular.  
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Figure 3.5 Immunohiscochemistry images of human retinal macular region. Retinal ganglion cell 
markers, NeuN and Thy-1 labelled ganglion cells. The cell bodies in the retinal ganglion cell layer 
(RGCL), inner plexiform layer (IPL), inner nuclear layer (INL), outer plexiform layer  (OPL) and outer 
nuclear layer (ONL) were stained by DAPI (blue). NeuN and Thy-1 stained the cell body in the RGCL 
and a few in the INL.  
 
 
 
 
 
 
71 
!"#!$%
!&"'%
($'%
)$'%
(*'%
)*'%
+,*(%-./0.%
1234%
 
Figure 3.6 Immunohiscochemistry images of human retinal macular region. Photoreceptor cell 
marker, RCVRN, labelled outer retina layers. The cell bodies in the retinal ganglion cell layer (RGCL), 
inner plexiform layer (IPL), inner nuclear layer (INL), outer plexiform layer  (OPL) and outer nuclear 
layer (ONL) were stained by DAPI (blue).  
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3.3 Discussion 
Retinal morphology was retained in human retina within 24h post mortem. The retinal 
macular region contained abundant retinal ganglion cells compared with para-macular and 
peripheral regions. The central macular region is approximately 2% of the area of the whole 
retina, but contains over 30% of RGCs (Curcio and Allen 1990). The RGCL thickness in the 
central retina has been reported to be 60-80µm decreasing to 10-20µm in the periphery 
(Forrester, Dick et al. 2002). Our retinal macula samples with histological H&E staining 
verified that the retina macular region contained the thickest retinal ganglion cell layer 
(RGCL) and highest numbers of RGCs.  
 
In this study a new technique has been developed, which offers a powerful and practical 
method to obtain relatively high quantities of mRNA from the human RGC layer. The gene 
expression profiles of different retinal cell markers, RCVRN, CALB, CHAT and THY-1, for 
photoreceptor cells, horizontal cells, amacrine cells and ganglion cells respectively (Figure 
3.2 and 3.3), were highly consistent with the known structure of the retina. Furthermore, 
when the profiles of two further RGC markers were investigated, Brn3a (POU class 4 
homeobox 1) and NeuN (RNA binding protein, fox-1 homolog (C. elegans) 3, RBFOX3) 
they were found to correspond with that for THY-1.    
 
To confirm the mRNA profiles Immunohistochemistry was used. NeuN is a neuronal specific 
protein which labels RGCs in the RGCL and INL (Mullen, Buck et al. 1992; Wolf, Buslei et 
al. 1996). It was widely used to determine RGC number changes in experimental models of 
glaucoma (Buckingham, Inman et al. 2008; Niyadurupola, Sidaway et al. 2011; Niyadurupola, 
Sidaway et al. 2013). Thy-1 is a cell surface antigen which label the cell body and cell 
processes (Barnstable and Drager 1984). It was widely utilized in the immune-panning 
procedure to purify RGCs (Barres, Silverstein et al. 1988; Zhang, Liu et al. 2010; Hong, 
Iizuka et al. 2012). Recoverin is expressed in both rod and cone photoreceptor cell (Dizhoor, 
Ray et al. 1991; Haverkamp and Wassle 2000). In the human retina, NeuN and Thy-1 were 
seen to label RGCs in the RGCL and only a few displace RGCs in the INL; RCVN staining 
was seen in the ONL and OPL. These immunoreactivities supported their mRNA profiles in 
the human retina. 
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Overall, these data show that the technique developed to give horizontal planar sections of 
the retina was successful. Having developed the technique it can be used to study expression 
of genes of interest across the human retina. By isolating mRNA from the RGCL, gene arrays 
can be used to study gene expression in this region of the human retina.    
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Chapter 4 
Expression profiling of genes in human retinal ganglion cells 
using a novel sectioning technique 
 
4.1 Introduction: 
In the research discussed in the previous chapter, a novel sectioning technique was 
developed, which enabled isolation of the RGCL from entire retina. This layer predominantly 
contains the retinal ganglion cells, which are the neuronal cells that take the visual 
information from the sensory retina to the brain. RGC degeneration is linked to several 
diseases, particular glaucoma. Previous reports have demonstrated that in glaucoma RGCs 
were severely affected and the thickness of RGCL is greatly decreased, both in experimental 
glaucoma and glaucoma patients (Kendell, Quigley et al. 1995; Osborne, Ugarte et al. 1999; 
Kielczewski, Pease et al. 2005). In order to enable to understand more about the cellular 
processes that might be involved in RGC degeneration in glaucoma, it is important that genes 
expressed in human RGCs are identified. 
As same in all cells, genes regulate the whole life of the RGCs, from embryonic development 
to differentiation and to RGC apoptosis. Gene mutations have been shown to cause various 
retinal diseases (Siegert, Cabuy et al. 2012). For example, the absence of cytochrome P450, 
family 1, subfamily B, polypeptide 1 (CYP1B1) has been shown to be relevant to primary 
congenital glaucoma (Dimasi, Hewitt et al. 2007) and its overexpression promotes RGCs 
survival (Wang, Kunzevitzky et al. 2007). Deficiency of chemokine (C-X3-C motif) receptor 
1 (CX3CR1) contributed to the disease progression of age-related macular degeneration 
(Chen, Connor et al. 2007). 
Global gene expression studies have been carried out investigating the expression profile of 
RGCs in animal models (Farkas, Qian et al. 2004; Ivanov, Dvoriantchikova et al. 2006; 
Wang, Kunzevitzky et al. 2007) and also human retina recently (Kim, Kuehn et al. 2006). As 
the immunopanning was successfully developed to isolate RGCs in the rat, the gene 
expression profiling was put into practice using purified RGCs (Farkas, Qian et al. 2004; 
Ivanov, Dvoriantchikova et al. 2006). Gene microarray of purified rat RGCs, which 
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compared with the whole retina, was found out that majority of RGC markers had been 
included in RGC-enriched microarray list. Moreover, there was a group of genes which 
related to cell pro-survival, such as Nrg1, Rgn and Nrn1, was revealed highly expressed in 
RGCs. Unfortunately, there was few successful attempt to purify the human RGCs. However, 
the gene expression profiling of human RGCL was obtained using LCM, and it was 
compared with the rest layers of retina (Kim, Kuehn et al. 2006). Some research groups also 
set up experimental glaucoma models to assess the alteration of gene expression of RGCL 
using LCM and immunopanning (Ahmed, Brown et al. 2004; Soto, Oglesby et al. 2008; Guo, 
Cepurna et al. 2010).  
In the previous chapter the RGCL was successfully separated from the entire retina, 
therefore, this technique was used to isolate RGCL mRNA in order to perform gene array 
analysis. Two groups of gene array data were obtained, one for the RGCL (isolated from the 
macular region) and the other for the entire macula (Mac). The aim of the research presented 
in this chapter was to compare the gene expression of the RGCL with the Mac, to find out the 
most expressed genes in the RGCL relative to the whole retina. This may identify genes of 
specific importance to the retinal ganglion cells. 
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4.2 Result: 
4.2.1 Selection of RGCL samples for Illumina gene arrays 
Retinal macular samples were sectioned and collected by our planar sectioning technique to 
isolate the RGCL from the retina. The mRNA samples from each macula were measured and 
the expression of the RGC cell marker, THY-1, was determined by QRT-PCR. Figure 4.1 
shows the THY-1 expression profile for a single macula. Three sections were then chosen: 
the sample with the peak expression and its next-door neighbors. These three samples were 
combined. For the control group, RNA was isolated from the entire macula (Mac). For each 
eye, over 100ng of RNA was processed for gene array analysis. There were 5 samples in total 
from each group (RGC and Mac). These samples were send to Source Bioscience 
(Nottingham, UK) and processed Illumina gene microarray.  
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Figure 4.1 The expression of THY-1 across the retina macular sections, measured by QRT-
PCR. The red dots were the sample selected as RGCL sample for array analysis. The expression 
was normalised to the highest expression.  
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4.2.2 Illumina gene arrays and analysis 
Global gene expression analysis using Illumina gene arrays was carried out to identify genes 
expressed in human RGCL. RNA samples were either from the RGC layer (n=5) obtained by 
cryosectioning or from Mac samples (n=5). RNA integrity was assessed by running a small 
aliquot from each sample on an Agilent Bioanalyzer 2100 using RNA 6000 Nano or Pico 
Assay. Most samples had a high RNA integrity number (RIN > 8), apart from one where RIN 
was 6.9, indicating they were good quality samples with sufficient integrity to be used for 
further gene array analysis. 
 
 
Table 4.1 RNA viability for array samples. The RNA integrity number (RIN) provides information on 
the presence or absence of RNA degradation products. A RIN number of 10 indicates perfect, 5 
partially degraded and 1 totally degraded RNA.   
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The samples were grouped into different phenotypes by constructed hierarchical plot, which 
based on expression of 7953 genes (Figure 4.2). These two phenotypes were from RGCL and 
Mac, respectively. And the five RGCL samples were all closely related, indicating that 
sample selection was appropriate.  Furthermore, when a heat-map was produced of the top 50 
most expressed genes in the RGCL compared to the whole macula, it can be seen that the 
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individual samples are very well segregated. They also shown that the individual variation 
between each sample in the two groups was low: with only 2 exceptions all of the RGCL 
samples were red for each of these genes. 
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Figure 4.2 Sample relationship based on expression of 7953 genes with sd/mean >0.1.The 
samples were split into two groups. These samples from sam  phenotype were grouped together.  
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Figure 4.3 The heat map of the top 50 features of RGC. The red colour means positive correlated, 
the green means negative correlated.  
 
 
Data analysis compared gene expression in the RGCL to whole macular samples (MAC). The 
7953 genes were retained only if they were presented over 50% of one phenotype, which 
were further analyzed. The most “upregulated genes” are therefore those most highly 
expressed in the RGC layer compared to the entire macula. The most “downregulated genes” 
are those expressed most highly in the entire macula compared to the RGCL.  
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4.2.3 Gene array analysis: RGCs vs entire macula 
Gene array analysis compared gene expression levels in the RGCL to the whole macula. A 
total 34689 gene were tested on the RGC samples and Mac samples. Expressions of 820 
genes were detected as present in either RGCL or Macular samples. 359 genes were 
identified with higher expression (>1.3-fold enrichment) in the RGCL (p<0.05) compared to 
461 genes (include ribosomal encoding genes, duplicate genes and uncharacterized genes) 
showing over 1.3-fold greater expression in the whole macula. Table 2.1 shows the most 
enriched genes in the RGCL compared to the entire macula (>2-fold). In these most up-
regulated genes, several genes are specific to neuronal development and neurogenesis, such 
as ZFHX3, EBF1 and MAP1B. Heat shock protein 70KDa protein 1B (HSPA1B) and 
AHNAK nucleoprotein 2 (AHNAK2) were the most highly expressed two genes in the 
RGCL (Table 4.2), and are possible new candidates for RGC markers. Importantly the RGC 
and axon markers, POU4F1, TUBB3, THY-1 and NFH were included in the most expressed 
genes (fold change >2) in the RGL. NeuN, however, did not appear in the gene list.
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Order No. in 
list Official symbol Official full name Fold change 
1 HSPA1B  eat shock 70kDa protein 1B  3.22 
2 AHNAK2  AHNAK nucleoprotein 2  2.61 
3 ZFHX3  Zinc finger homeobox3  2.54 
4 SCN1A  Sodium channel, voltage-gated, type 1, alpha subunit  2.48 
5 EBF1  Early B-cell factor 1  2.47 
6 SORL1  Sortilin-related receptor, L (DLR class) A repeats containing  2.40 
7 MAP1B  Microtubule-associated protein 1B  2.36 
8 KANK4  KN motif and ankyrin repeat domain 4  2.35 
9 NPR3  Natriuretic peptide receptor C/guanylate cyclase C (atrionatriuretic peptide receptor C) 2.32 
10 IRX2  Iroquois homeobox 2  2.25 
11 RYR2 Ryanodine receptor 2  2.17 
12 C20ORF46 Transmembrane protein 74B 2.16 
13 DYNC1H1 Dynein, cytoplasmic 1, heavy chain 1 2.16 
14 EPDR1 Ependymin related protein 1 2.15 
15 POU4F1 POU class 4 homeobox 1 2.14 
16 PANX2 Pannexin 2 2.13 
17 EBF3 Early B-cell factor 3 2.12 
18 PRUNE2 Prune homolog 2  2.11 
19 ELAVL2 ELAV (embryonic lethal, abnormal vision, Drosophila)-like 2 (Hu antigen B) 2.11 
20 B4GALT5 UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5 2.10 
21 SCN2A Sodium channel, voltage-gated, type II, alpha subunit 2.09 
22 EPB49 Dematin actin binding protein 2.08 
23 PRICKLE1 Prickle homolog 1 2.07 
24 HSPA1A Heat shock 70kDa protein 1A 2.07 
25 EPHA4 EPH receptor A4 2.07 
26 TUBB3 Tubulin, beta 3 class III 2.07 
27 HAPLN4 Hyaluronan and proteoglycan link protein 4 2.06 
28 HS.4892 EFR3 homolog B 2.05 
29 KIF5A Kinesin family member 5A 2.04 
30 CDR2L Cerebellar degeneration-related protein 2-like 2.04 
31 ODZ4 Teneurin transmembrane protein 4 2.04 
32 CAPN1 Calpain 1, (mu/I) large subunit  2.04 
33 THY1 Thy-1 cell surface antigen 2.04 
34 HSPA8 Heat shock 70kDa protein 8 2.03 
35 NEFH Neurofilament, heavy polypeptide 2.03 
36 TMEM163 Transmembrane protein 163 2.02 
37 RPS23 Ribosomal protein S23 2.02 
38 KISS1R KISS1 receptor 2.00 
39 HSPB7 Heat shock 27kDa protein family, member 7 (cardiovascular) 2.00 
40 GRIN1 Glutamate receptor, ionotropic, N-methyl D-aspartate 1 2.00 
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The genes listed in Table 4.3 were those with the highest relative expression in whole 
macula compared to the RGCL. Most genes in this list were involved in the 
phototransduction pathway. There is just one exception, RAX2, a transcription factor 
which has been reported to be essential in eye development and in modulating gene 
expression in photoreceptor cells (Wang, Chen et al. 2004). 
 
 
Table 4.3 The “down-regulated genes”, which were most differently expressed in the 
MAC compared with RGCL.These genes were placed from the biggest fold change to the 
smaller. 
Order 
No. in list 
Official 
symbol!
Official full name! Fold change!
1! PDE6H! Phosphodiesterase 6H, cGMP-specific, cone, 
gamma! 17.58!
2! OPN1LW! Opsin 1 (cone pigments), longwave-sensitive! 17.37!
3! OPN1MW! Opsin 1 (cone pigments), mediumwave-sensitive! 14.64!
4! ARR3! Arrestin 3, retinal (X-arrestin)! 14.15!
5! GNAT2 Guanine nucleotide binding protein (G-protein), 
alpha transducting activity polypeptide 2! 10.54!
6! SAG! S-antigen; retina and pineal gland (arrestin)! 9.86!
7! GUCA1B! Guanylate cyclase activator 1B (retina)! 9.28!
8! RAX2! Retina and anterior neural fold homeobox 2! 8.79!
9! GUCA1A! Guanylate cyclise activator 1A! 8.47!
10! CNGA1! Cyclic nucleotide gated channel alpha 1! 8.28!  
 
 
4.2.4 Expression profiles of HSPA1B and AHNAK2 
In order to validate the array results, QRT-PCR was used to measure expression of 
genes with high expression in the RGC or whole macula. The top two most highly 
expressed in the RGCL genes (HSPA1B and AHNAK2) (Table 4.2) and one of the 
genes (OPN1LW) most highly expressed in whole macula were selected to carry out 
QRT-PCR in samples from 4 additional retinas. These were compared to the RGC 
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and photoreceptor markers THY-1 and RCVRN. The distribution of AHNAK2 was 
closely associated with the RGC marker, THY-1 (Figure 4.4). The expression of 
AHNAK2 in the photoreceptor layer was negatively associated with the photoreceptor 
cell marker, RCVRN. AHNAK2 presented 2.61-fold enrichment in the RGCL 
compared to the photoreceptor layer (Figure 4.4).  
 
HSPA1B is another gene relatively highly expressed in the RGC gene list. Its 
expression also associated with THY-1 and AHNAK2, but it is more variable. It was 
higher in the inner retina compared to the outer retina, giving a 3.22-fold enrichment 
in the RGCL. OPN1LW was highly expressed in the photoreceptor layer and very 
limited expression was detected in the inner retina. Distribution was similar to 
RCVRN although the profile for OPN1LW showed a steeper decline than RCVRN. 
Its expression was 17.37-fold greater in the photoreceptor cell compared with RGCs, 
whereas RCVRN was 7.34-fold (Figure 4.4). 
 
 
 
Figure 4.4 The expression profile of HSPA1B, AHNAK2 and OPLW1 in human retina 
compared to the selected marker genes THY-1 and RCVN. Serial cryosections were taken 
and gene expression was measured by QRTPCR. n=4. 
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4.2.5 Localisation of RGC markers in the human retina 
AHNAK2 displayed highest immunoreactivity in the RGCL. It also presented very 
limited staining in the OPL and outer segment layer (Figure 4.5). HSP1AB staining 
was seen throughout the retina, although staining appeared to be most intense in the 
RGCL and was extensively colocalised with NeuN (Figure 4.6). RCVRN is a marker 
that labels both rod and cone photoreceptor cells. It exclusively stained in the OPL, 
ONL and outer segment layer (Figure 4.6). 
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Figure 4.5 Transverse retinal sections immune-labelled with antibodies against the 
photoreceptor cell marker, RCVRN (red), and co-labelled with AHNAK2 (green). The cell 
nuclei was labelled with DAPI (blue). ONL, outer nuclei layer; OPL, outer plexiform layer; INL, 
inner nuclei layer; IPL, inner plexiform layer; RGCL, retinal ganglion cell layer. 
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Figure 4.6 Transverse retinal sections immuno-labeled with antibodies against the 
RGC markers, NeuN, THY-1, Tubulin and neurofilament heavy chain (green), HSPA1B 
(red). The cell nuclei were labelled with DAPI (blue). ONL, outer nuclei layer; OPL, outer 
plexiform layer; INL, inner nuclei layer; IPL, inner plexiform layer; RGCL, retinal ganglion cell 
layer. 
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4.3 Discussion 
Gene array analysis has identified a large number of genes, which were preferentially 
expressed in the RGC layer. Some of the genes which identified in this study have not 
been previously linked with RGCs. Retinal sections of entire macular were obtained 
with high quality RNA by using our novel planar section technique. RGCL samples 
were successfully isolated from the retina as they were grouped together as same 
phenotype, which were apart from the Mac samples. Heat map of top 50 arrays 
samples shown that all the sample were classified into two phenotypes, even they 
have individual variations as been excepted when using human tissue. The validity of 
Illumina gene array data was checked using three representative genes, which were 
highlighted by the array. They were in fact expressed in the human retina by testing 
both PCR and immunoreaction.  
 
The genes identified can be separated into a number of functional groups. The most 
noticeable are members from heat shock protein (HSP) family. Of all RGCL enriched 
genes (fold change >2), 4 genes belong to the HSP family and three of these were 
from the 70kDa heat shock protein gene family (HSP70) (Table. 4.4). A further two 
HSP genes, HSP105 and HSP10, were found in the list of genes with >1.5-fold 
enrichment (Table 4.4).  
 
Heat shock proteins (HSPs) are highly conserved proteins which involved in cell 
survival by upregulated its expression and against cell apoptosis pathway under 
pathological conditions (Takayama, Reed et al. 2003; Beere 2005). They are 
important in early immune response in tissue under environmental stress (Wax and 
Tezel 2009). Several reports have indicated that antibody levels to HSPs were 
elevated in serum, aqueous humor and the optic nerve head in glaucoma patients 
(Tezel, Hernandez et al. 2000; Joachim, Bruns et al. 2007a; Joachim, Wuenschig et al. 
2007b).  
 
It was observed that cultured rat RGCs increased HSP72 expression after 
hyperthermia (42˚C, 1h) and hypoxia (6h) treatment (Caprioli, Kitano et al. 1996). 
These pretreated cells were then found to have greater resistance to anoxia (6h) or 
glutamate treatment (6h) exposure (Caprioli, Kitano et al. 1996). It has also been 
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shown that the small heat shock proteins (aA- and aB-crystallin and HSP27) are 
elevated in glaucoma patients, and that this is greater in normal pressure glaucoma 
patients compared to those with primary open angle glaucoma (Tezel, Seigel et al. 
1998; Wax, Tezel et al. 2000). Furthermore, in experimental glaucoma there is 
increased expression of HSPs, particular HSP27, in both RGCs and glial cells (Huang, 
Fileta et al. 2007). This may suggest that HSPs have an important role in assisting 
RGCs in maintenance of cell function and resisting stressful insults.  
 
 HSP70 is a group of highly conserved protein which contains 13 members, such as 
HSPA1A and HSPA1B. HSPA1A and HSPA1B are two stress-inducible and intronless 
genes that have almost identical sequences with only two amino acids different 
(Kampinga, Hageman et al. 2009). They were not able to be distinguished by most 
methods, including the protein level (Scieglinska, Piglowski et al. 2011). HSP70 
functions as a chaperone molecule to supervise protein denaturation, translocation, 
correct folding, activation and aggregation (Takayama, Reed et al. 2003). HSP70 has 
a potential neuroprotective function when over-expressed and has been shown to 
protect some neuron cells from certain stressful insults, including oxidative stress 
(Yenari, Giffard et al. 1999; Kalmar and Greensmith 2009). A recent report has 
indicated that HSP70 is specifically expressed in RGCs and is the earliest gene was 
induced after optic nerve injury, crucial for RGCs survival in the zebra fish retina 
(Nagashima, Fujikawa et al. 2011). Heat shock 70kDa protein 8 (HSPA8 or HSC70), 
shares 85% sequence homology with HSP70 and has similar functions to the other 
members of HSP70 family (Liu, Daniels et al. 2012). HSP70 and HSC70 expressions 
were also enhanced after cerebral ischemia (Muranyi, He et al. 2005). Furthermore, 
administration of HSP/HSC70 to the neonatal mouse with traumatic injury can reduce 
subsequent apoptotic loss of neurons (Tidwell, Houenou et al. 2004). Thus, HSP70 
and HSC70 appear to play a positive role in neuroprotection. 
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Table 4.4 Genes of the heat shock protein family with greater expression in the RGCL 
in the human retina. 
Official symbol! Official full name! Fold change!
HSPA1B (HSP70-2)! Heat shock 70kDa protein 1B.! 3.22!
HSPA1A (HSP70-1)! Heat shock 70KDa protein 1A.! 2.07!
HSPA8 (HSC70)! Heat shock 70kDa protein 8.! 2.03!
HSPB7 ! Heat shock 27KDa protein family, member 7.! 2.00!
HSPH1 (HSP105)! Heat shock 105/110 KDa protein 1.! 1.79!
HSPE1 (HSP10)! Heat shock 10kDa protein 1.! 1.54!
 
 
 
A second functional group of genes up-regulated in RGCL were several transcription 
factors (Table 4.5). ZFHX3, EBF1 and IRX2 were included in the top 10 RGCL 
genes. Both Ebf1 and Ebf3 have been detected in the developing retina of mouse 
(Davis and Reed 1996; Wang, Tsai et al. 1997; Wang, Tsai et al. 1997; Trimarchi, 
Stadler et al. 2007). EBF1 has also been previously shown to be expressed in the 
RGCL of human retina (Kim, Kuehn et al. 2006). Knockdown of EBF1 in mouse 
retinas, caused abnormal RGC axons at the optic chiasma and increased numbers of 
Müller glial cells in the retina (Jin and Xiang 2011). These data suggest that they are 
also important transcription factors in the human retina. ZFHX3 is found in the central 
nervous system where it participates at an early stage in visual sensory development. 
It also promotes the differentiation and proliferation of neuronal cells (Watanabe, 
Miura et al. 1996; Jung, Kim et al. 2005; Kim, Kawaguchi et al. 2010). ZFHX3 has 
been found to activate platelet-derived growth factor (PDGF) receptor b, a neuronal 
survival factor, considered to be a protector when cerebellar neurons suffer oxidative 
stress (Kim, Kawaguchi et al. 2010). This may be significant in the retina, where it 
has been shown the PDGF is neuroprotective (Kim, Kawaguchi et al. 2010).  IRX2 is 
a member of Iroquois homeobox gene family. Another closely related gene, IRX3 
(FDC=1.88), was also detected in the RGCL in this study.  
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Table 4.5 Transcription factor genes of with greater expression in RGCL in the human 
retina. 
Official symbol Official full name Fold change 
ZFHX3  Zinc finger homeobox3  2.54 
EBF1  Early B-cell factor 1  2.47 
IRX2  Iroquois homeobox 2  2.25 
POU4F1 POU class 4 homeobox 1 2.14 
 
 
 
A third group of genes which was upregulated in the RGCL were ion channels and 
ion associated proteins. Several sodium-related genes (Table 4.6) and calcium- related 
genes (Table 4.7) were presented. AHNAK2 encodes a calcium-associated protein, 
which is an unusually large (approximately 700KDa) and propeller-like protein. It is 
the second most highly expressed gene in the RGCL that is first time determined its 
distribution in the retina. RyR2 is a ryanodine receptor calcium channel, which was 
found on the ER membrane and participates in Ca2+ from the internal store. Cyclic 
ADP-ribose (cADPR) can act as an endogenous stimulus at RyRs to induce Ca2+ 
release. In retinal cells, RyR2 has been found was more widely expressed than other 
RyRs. CAPN1 is one of ubiquitous calpains, which are calcium-dependent cysteine 
proteases (Johnson and Guttmann 1997; Ono and Sorimachi 2012). Calpain-1 has 
been shown that highly expressed in RGCs in the rabbit retina (Croall and Demartino 
1991). Calpain activation has been testified that involved in ischemia/hypoxia-
induced retinal cell death in both in vivo (Sakamoto, Nakajima et al. 2000; Tamada, 
Nakajima et al. 2005) and in vitro in animal models (Tamada, Fukiagea et al. 2002; 
Tamada, Nakajima et al. 2005). GRIN1 is a glutamate receptor. Glutamate receptor 
has been widely studied in the retina, which its activation involves in ischemia 
induced RGC death by increased the cellular calcium.    
 
SCN1A was one of top 10 RGCL enriched genes. It is the alpha subunit of the Type I 
voltage-gated sodium channel. In addition to SCN1A, another two members of 
voltage-gated sodium channel, SCN2A and SCN2 were also detected as having greater 
expressions in the RGCs. These code the alpha and beta subunits of the Type II 
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voltage-gated sodium channel. It would be expected that expression of voltage-gated 
sodium channels would be abundant in the RGCL, since the fundamental role of the 
RGCs is to conduct action potentials along its axons to take visual information to the 
brain.  
 
 
Table 4.6 Calcium-related genes with greater expression in RGCL in the human retina. 
Official symbol! Official full name! Fold change!
AHNAK2  AHNAK nucleoprotein 2  2.61!
STX1B?
Syntaxin 1B, calcium-dependent cellular receptor for 
Synaptic transmission.?
2.20?
  RYR2? Ryanodine receptor 2  2.17 
CAPN1? Calpain 1, (mu/I) large subunit.? 2.04?
GRIN1? ?Glutamate receptor, ionotropic, N-methyl D-aspartate 1 2.00?  
 
 
Table 4.7 Sodium-related genes with greater expression in RGCL in the human retina. 
Official symbol Official full name Fold change 
SCN1A  Sodium channel, voltage-gated, type 1, alpha subunit  2.48!
SCN2A? Sodium channel, voltage-gated, type II, alpha subunit.? 2.09?
SCN2B? Sodium channel, voltage-gated, type II, beta subunit? 1.91?  
 
 
The rest of the RGCL enriched genes encode genes for cytoplasmic components, 
membrane structural proteins or RNA binding proteins. Some have interesting 
connections to neurodegenerative disease. SORL1 expression associates with 
Alzheimer’s disease as it regulates activities of amyloid precursor protein (Klinger, 
Glerup et al. 2011; Lao, Schmidt et al. 2012). MAP1B is a member of microtubule-
associated protein that promotes microtubule assembly and is up-regulated during 
axonal growth of developing neurons and in regeneration in the CNS (Bates, Trinh et 
al. 1993; Tymanskyj, Scales et al. 2012). NPR3 codes one of the natriuretic peptide 
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receptors. These have previously been shown to be widely expressed in the CNS, 
including in the retina (Cao and Yang 2008). NPR3 has also been shown to be 
expressed in the human retina, (Rollín, Mediero et al. 2004) and in rat has been 
detected in RGC membranes (Xu, Tian et al. 2010).  
 
In this study a new technique has been developed, which offers a powerful and 
practical method to obtain relatively high quantities of high quality mRNA from the 
human RGC layer. Using Illumina gene array technology the genes that are most 
highly expressed in the RGCL from the macula compared to the whole macula in 
human retina. Several genes were identified which may have crucial contributions for 
retinal ganglion cell functions. Furthermore, the data has identified new candidates for 
specific markers of retinal ganglion cell, especially AHNAK2. Finally, our study has 
identified targets that warrant further research in relation to targeting RGC 
degeneration in glaucoma. There are several interesting genes were highlighted in the 
RGCL up-regulated list, whereby, most interesting ones were calcium- related group. 
Glutamte is excitotoxicity which lead to [Ca2+]i overload. Consequently, the calcium-
depend cellular pathways will be activated and stimulated cell death. In the following 
chapter, calpain, which has been found by gene array will be identified in greater 
detail, and investigate its role in relation to neurodegeneration in the human retina. 
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Chapter 5 
Calpain activation and retinal ganglion cell death in HORCs 
induced by retina ischemia 
 
5.1 Introduction: 
In the previous chapter, several calcium-related genes presented greater expressions in 
the RGCL which included one of calpain member. Calpain activation contributed to 
neural cell death under the ischemia condition (Rami 2003). The causes of RGC death 
in glaucoma remain unclear, but retinal ischemia is proposed to play an important role 
(Osborne, Casson et al. 2004). During retinal ischemia, calcium homeostasis is 
breakdown (Crish and Calkins 2011).  
 
Excitotoxicity by glutamate has been proposed as the mechanism by which retinal 
ischemia leads to Ca2+ overload and subsequent RGC death (Goll, Thompson et al. 
2003; Chiu, Lam et al. 2005). In an ischemia/reperfusion experimental model, 
glutamate has been measured at the retinal surface during the retinal ischemia and 
following reperfusion (Louzadajunior, Dias et al. 1992). Glutamate levels increased as 
a result of ischemia, but greater levels were seen after reperfusion. Release of 
glutamate causes over-activation of both NMDA and non-NMDA glutamate 
receptors. NMDA receptors, are inotropic glutamate receptors, which are highly 
permeable to Ca2+ and Na+ allowing these ions to enter the cells (Szydlowska and 
Tymianski 2010). Activation therefore leads to Ca2+ influx and elevated [Ca2+]i. 
Isolated rat RGCs show increased [Ca2+]i when treated with glutamate (Miao, Dong et 
al. 2012) and MK801, an antagonist of NMDA, has been shown to protect the retina 
following ischemic insult (Lam, Siew et al. 1997). The NMDA receptor is extensively 
expressed in the retina, including in RGCs (Yin Shen 2006). Furthermore, the NMDA 
receptor subunit GRIN1 was one of the genes identified as being enriched in the 
human RGCL (Chapter 4). The increase in intracellular Ca2+ caused by excitotoxic 
mechanisms could, in turn, lead to activation of calcium-activated enzymes, such as 
calpain. The large subunit of calpain 1 was also one of the genes identified as being 
enriched in the human RGCL (Chapter 4). 
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5.1.1 Calpain-1 and calpain-2 
The calpains are a family of calcium-dependent cysteine proteases (Johnson and 
Guttmann 1997; Ono and Sorimachi 2012). Calpain-1 (µ-calpain) and calpain-2 (m-
calpain) are ubiquitously distributed and the most extensively studied isoforms of 
calpain. They have similar characteristics, but are activated by different Ca2+ 
concentrations, with calpain-1 being activated at lower concentrations than calpain-2. 
Calpains have a number of substrates, but key substrates are cytoskeletal proteins, 
such as spectrin, tubulin, vimentin (Goll, Thompson et al. 2003). Spectrin is a 
cytoskeletal protein that is proteolsed both by calpain and caspase-3. A 145-kDa 
fragment is specifically generated by calpain and 150-kDa fragments are produced by 
both calpain and caspase-3 in apoptotic cells (Nath 1996; Huang, Fileta et al. 2010). 
Both of these fragments are generated under the pathological conditions, and are early 
markers of neurodegeneration (Huang, Fileta et al. 2010).  
 
5.1.2 Calpain activation and neurodegeneration in the retina 
Calpain activation has been well studied in brain ischemia, where degeneration of 
cytoskeletal proteins by calpain led to neuronal cell death (Yamashima 2000; Huang 
and Wang 2001; Rami 2003). In the retina, it has been found that calpain activation is 
involved in ischemia/hypoxia-induced retinal cell death in both in vivo (Sakamoto, 
Nakajima et al. 2000; Tamada, Nakajima et al. 2005) and in vitro in animal models 
(Tamada, Fukiagea et al. 2002; Tamada, Nakajima et al. 2005). Activation has also 
been observed in an experimental model of glaucoma (Huang, Fileta et al. 2010). In 
addition, calpain-1 activation showed a time dependent increase after the rat retina 
was subjected to intravitreal injection of NMDA (Chiu, Lam et al. 2005). Calpain-2 
and spectrin breakdown products (SBDPs) were also increased after exposure of rat 
RGCs to glutamate in isolated rat retinal neurons, and the formation of SBDPs was 
inhibited by glutamate receptors antagonists (Miao, Dong et al. 2012). There is 
therefore good evidence that calpain can be activated in the retina in models of 
glaucoma. 
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5.1.3 Calpain inhibitors 
There are numerous different calpain inhibitors and several of them have been used to 
investigate neuroprotection in the retina (Paquet-Durand, Johnson et al. 2007; Azuma 
and Shearer 2008). Calpain inhibitor II, N-Acetyl- Leu-Leu-Met-CHO (ALLM), has 
been shown to protect RGCs against NMDA induced excitotoxicity (Chiu, Lam et al. 
2005). Other inhibitors produced by the company Senju Pharmaceutical Co., Ltd, 
have also been investigated, for example SNJ-1945 and SJA6017. SNJ-1945 was 
found to prevent RGC death following axonal damage (Ryu, Yasuda et al. 2012), and 
SJA6017 partially protected RGCs from IOP induced hypoxic-injury (Nakajima, 
David et al. 2006). MDL28170 (also known as calpain inhibitor III; Z-Val-Phe-CHO) 
is a potent inhibitor of both calpain-1 and calpain-2. It has been shown to exhibit a 
neuroprotective role in excitotoxicity by glutamate in in vitro (Brorson, Marcuccilli et 
al. 1995; Bi, Jin et al. 2012), and in vivo model of brain ischemic injury (Lia, Howlett 
et al. 1998). In fact, administration of the drug 7 hours after global brain ischemic 
insult was still able to offer neuroprotection in the rodent (Lia, Howlett et al. 1998). It 
has not previously been used to investigate neuroprotection in the retina. 
 
The aim of the research presented in this chapter was to investigate (1) whether 
simulated ischemia could induce calpain activation in HORCs; (2) whether MDL 
28170 could prevent calpain-mediated proteolysis and protect RGCs from ischemia 
induced death. 
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5.2 Results: 
5.2.1 The profiling of calpain-1 and calpain-2 in the human retina 
In order to assess whether calpain-1 or calpain-2 are expressed in human retina and 
the expression profile across the retinal layers, cryo-sectioning together with QRT-
PCR (as described in chapter 3) were used. The pattern of Calpain-1 (CAPN1) 
expression was very similar to that of THY-1, starting low at the baseline in the outer 
retina sections and increasing to peak expression in the inner retinal sections. The 
peak of CAPN1 expression coincided with peak of THY-1, although was higher than 
THY-1 in the mid-retina layers (Figure 5.1 A). The pattern of Calpain-2 (CAPN2) 
expression showed relatively higher expression in the inner retina but was more 
evenly distributed than CAPN1, with the expression seen also in the outer retinal 
sections. The total amount of mRNA for CAPN1 and CAPN2 is shown in Figure 5.1 
B. The results show that both of these two genes were present predominantly in the 
inner retina, with CAPN1 having a more differential distribution through retinal 
different layers. This was in accordance with the gene array analysis. The heat map 
showed that CAPN1 had different expression in the macular samples (Mac1-5) and 
retinal ganglion cell layer sections (RGCL1-5) (Figure 5.2.A), and the analysis 
documented that there was a 2.03-fold change (Figure 5.2.B). For CAPN2 differential 
expression could not be detected by the arrays.  
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Figure 5.1 (A). Calpain-1 (CAPN1) and calpain-2 (CAPN2) mRNA expression across the 
retina (mean ± S.E.M.) expressed as a percentage of the highest value (n=4 donor 
eyes). RCVRN -photoreceptor cell marker; THY-1 - RGC marker. (B) The average amount 
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of mRNA for CAPN1 and CAPN2 present in the sections with peak RCVRN and THY-1 
expression in planar retinal sections. 
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Figure 5.2 (A) Heat map of CAPN1 expression in entire macular (Mac 1-5) samples and 
retinal ganglion cell layer sections (RGCL1-5) samples. Red = higher expression; Green = 
lower expression. (B) Fold-change from Illumina gene arrays analysis of calpain-1 (CAPN1) 
and calpain-2 (CAPN2). 
 
 
Further investigation of the distribution of calpain-1 and -2 in the retina was carried 
out by immunohistochemistry. CAPN1 immunostaining mainly the existed in the 
RGCL but also appeared in the outer retina, plexiform layer (OPL), and there was 
some staining apparent in the outer nuclear layer (ONL) (Figure 5.3.A). CAPN2 
expression was associated with NeuN labeling of neuronal cells in the RGCL, but was 
nearly absent in the outer retina (Figure 5.3.B). These images suggested that both 
calpain-1 and 2 expressed in the human retina, and that calpain-2 was predominantly 
in the RGCL, whereas, calpain-1 was found in both inner and outer retinal layers. 
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Figure 5.3 (A) Macular retinal section labelled with RCVRN (red), CAPN1 (green) and 
DAPI (blue) using immunohistochemistry. (B) Macular section labelled with CAPN2 
(red), NeuN (green) and DAPI (blue) using immunohistochemistry. RGCL, retinal 
ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform 
layer; ONL, outer nuclear layer. 
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5.2.2 Simulated ischemia induced retinal cell death and calpain activation in 
HORCs 
In order to verify whether the calpain was activated in simulated ischemia, the oxygen 
glucose deprivation (OGD) model in human organotypic retinal cultures (HORCs) 
was used (Niyadurupola et al 2011). Using this model, it has been shown the OGD 
leads to a loss of RGCs in human retina.  α-spectrin and spectrin breakdown products 
(SBDPs) were measured by Western blot analysis as an assessment of calpain 
activation. HORCs were cultured in OGD for 5 time periods: 0 hour, 3 hours, 12 
hours, 18 hours, or 24 hours, then incubated in control medium for a further period 
(the “reperfusion” period), ending the experiment at 24 hours. The data was 
normalised by β-actin expression. The data shown that OGD induced the proteolysis 
of α-spectrin (Figure 5.4). Loss of full-length spectrin was detected at 3 hours and by 
12 hours approximately 80% was lost compared with the control (Figure 5.4A). 
SBDPs increased with OGD, showing an approximate doubling with 12 hours, 18 
hours and 24 hours OGD treatment (Figure 5.4B).  
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Figure 5.4 α-Spectrin proteolysis following simulated ischemia in HORCs with different 
time points. Western blots analysis of α-Spectrin (A) and SBDPs (B).  Level is measured by 
densitometry and expressed relative to β-actin (mean ± S.E.M; n=3 donors eyes).  
Representative blots are shown in (C) (★ p≤ 0.005; * p≤0.05;). 
 
 
The effects of simulated ischemia leaded to LDH leakage into the medium was 
measured for 3 hours and 12 hours OGD. LDH leakage gives an overall measurement 
of cell death in the retina. For the 3 hours OGD treatment, there was a significant 
increase (about 1.36 fold) in LDH leakage after at the end of the 24 hours period 
(Figure 5.5A). For the 12 hours OGD treatment, there was an increase of 
 101 
approximately 5 fold, both in the first 12 hours (when exposed to OGD) and in the 
subsequent 12 hours of reperfusion (Figure 5.5. B and C). This indicated that cell 
death had occurred as a result of simulated ischemia, with increased cell death 
following a longer exposure to OGD.  
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Figure 5.5 LDH release from HORCs following simulated ischemia. (A) LDH release from 
HORCs following 3 hours OGD/21 hours reperfusion. Measurement was from the medium 
sampled at the end of the reperfusion period (n=5 donor eyes, mean ± S.E.M.). (B) LDH 
release from HORCs during a 12 hours OGD compared to control (n=3 donor eyes, mean ± 
S.E.M.). (C) LDH release during the 12 hours reperfusion period following 12 hours OGD 
(n=3 donor eyes, mean ± S.E.M.). * P<0.05 VS control, ** P<0.01 VS control. 
 
 
To further investigate retinal cell death with simulated ischemia in HORCs, 
immunohistochemistry in conjunction with TUNEL staining was carried out. 
Following both 3 hours OGD/21 hours reperfusion and 12 hours OGD/12 hours 
reperfusion in HORCs, retinal cell number decreased in all the layers (Figure 5.6). 
After 12 hours OGD the majority of cells in all retinal layers were TUNEL positive. 
Furthermore, with 12 hours OGD/12 hours reperfusion, the retina showed an overall 
loss of structure. 
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Figure 5.6 Immunohistochemistry of 3 hours/21 hours and 12 hours/12 hours 
OGD/reperfusion. HORCs were stained with TUNEL (green), NeuN (red) and DAPI (blue). 
RGCL, retinal ganglion cell layer; INL, inner nuclear layer; ONL, outer nuclear layer. 
 
 
Taking the data from the proteolysis, LDH leakage and immunohistochemistry, 3 
hours OGD/21 hours reperfusion was taken as an appropriate protocol to investigate 
the effect of calpain inhibitors since this increased cell death and also proteolysis of 
spectrin, without causing extensive destruction. 
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5.2.3 Effects of the calpain inhibitor on proteolysis in HORCs with simulated 
ischemia. 
In order to verify whether the proteolysis of the cytoskeletal protein, α-spectrin, was 
via calpain activation, the inhibitor MDL-28170 was used, which inhibits both 
calpain-1 and calpain-2 activations (Kunz, Niederberger et al. 2004). 3 hours OGD/21 
hours reperfusion caused a loss of α-Spectrin (Figure 5.7). There was also an increase 
in SBDPs (both 145 and 150kDa), which were clearly separated in the gels (Figure 
5.7A). These breakdown products are both generated by calpain, but the band at 
145kDa is specifically produced by calpain, whereas the 150kDa band can also be 
produced by caspase-3 (Nath 1996). Simulated ischemia caused an increased in both 
products (lane I). The presence of the calpain inhibitor (lane I+i) protected against the 
loss of full-length spectrin and also decreased the amount of both of the SBDPs. 
Interestingly, there were higher level of spectrin and lower amounts of SBDPs with 
20µM MDL28170 compared to control (Figure. 5.7). These data give good evidence 
that calpain is activated by simulated ischemia 3 hour OGD/21 hours reperfusion and 
that calpain inhibiton can inhibit this activation.  
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Figure 5.7 (A) Representative Western blots of α-spectrin and its breakdown products 
from HORCs with simulated ischemia in the presence or absence of MDL28170. The 
HORCs were treated with either 3 hours OGD with (I+i) and without 20µM MDL28170 (I), or 
control with (C+i) and without MDL28170 (C). The black arrow points to the spectrin 
breakdown product of 150 kDa and the red arrow points to the breakdown product of 145 
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kDa. (B and C) Quantification (mean ± S.E.M.) of α- Spectrin expression (B) and SBDPs 
(C) in the HORCs (n=7 donor eyes). ** P<0.01. 
 
 
5.2.4 Role of calpain in simulated ischemia induced retinal cell death in HORCs 
The role of calpain activation in simulated ischemia-induced cell death was 
investigated by measuring LDH leakage. The HORCs were exposed to the inhibitor 
MDL28170 during both the OGD and the reperfusion phase. Exposing the HORC to 
the inhibitor did not increase the level of LDH release indicating that the inhibitor was 
not toxic to the retina. HORCs exposed to OGD showed a significant increase in LDH 
(approximately 30%) leakage compared to control. This was not inhibited by 20 µM 
MDL28170. This suggested that MDL28170 was unable to protect the retina from 
simulated ischemia.  
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Figure 5.8 LDH release from HORCs in simulated ischemia in the presence and 
absence of MDL28170. LDH levels in the medium from the reperfusion phase in control 
HORCs with/without 20 µM MDL28170 (Blue) and 3 hours/21 hours OGD/reperfusion 
with/without MDL28170 (Red) (n=5 donor eyes, mean ± S.E.M.). ** P< 0.01, control vs 
ischemia, and *P< 0.05, control +MDL28170 vs ischemia + MDL28170. 
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5.2.5 Calpain-induced RGC death in simulated ischemia in HORCs 
In order to investigate whether inhibition of calpain protected RGCs, 
immunohistochemistry was carried to assess the number of NeuN-labelled neuronal 
cells in the RGCL in HORCs exposed to simulated ischemia (3 hours OGD-21 hours 
reperfusion). In addition, TUNEL labelling was used to assess the level of apoptosis. 
In the presence of 20 µM MDL28170 alone, NeuN staining suggested that there was 
an increased number of RGCs compared to controls (Figure 5.9). When the number of 
cells was counted, there appeared to an increase, although this was not statistically 
significant (Figure 5.10). With simulated ischemia, there was a loss of NeuN positive 
RGCs (Figure 5.9 and Figure 5.10) and TUNEL staining increased. The calpain 
inhibitor 20 µM MDL28170 did not dramatically protect against the loss of RGCs and 
the small protection seen when the number of RGCs was counted, it was not found to 
be significant.  
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Figure 5.9 Representative immunohistochemical images of HORCs with simulated 
ischemia in the presence and absence of MDL28170. RGCs were labelled with antibody to 
NeuN (Red), TUNEL staining for apoptosis is shown in Green, and nuclei are stained with 
DAPI (blue). IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; 
ONL, outer nuclear layer.   
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Figure 5.10 Counts of NeuN labelled cells in the RGCL in the control with and without 
20 µM MDL28170, 3h/21h OGD/reperfusion with and without 20 µM MDL170 (mean ± 
S.E.M.; n=4 donor eyes). * p<0.05 vs control. 
 
 
Levels of THY-1 mRNA were also examined to further determine whether 
MDL28170 inhibited RGC death THY-1 mRNA in control was significant higher 
than in the 3 hours OGD/21 hours reperfusion HORCs (Figure 5.11). 20 µM 
MDL28170 alone had similar THY-1 expression to control. The addition of 20 µM 
MDL28170 did not increase THY-1 mRNA in the 3 hours OGD/21 hours reperfusion 
HORCs. 
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Figure 5.11 THY-1 level in 3 hours/21 hours OGD/reperfusion treated HORCs in the 
presence and absence of 20 µM MDL28170 THY-1 mRNA expression was normalised to 
geometric mean of TOP-1 and CYC-1 mRNA expression and expressed relative to 
control, (mean ± S.E.M.; n= 4 donor eyes). * p<0.05 vs control. 
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5.3 Discussion 
Although calpain-1 and calpain-2 are ubiquitously expressed and they are the major 
members of the calpain family these are active in the human (Nakajima, David et al. 
2006; Ono and Sorimachi 2012). Calpain-1 has been shown to have relatively high 
expression in RGCs in the rabbit retina (Croall and Demartino 1991). However, it has 
also been observed that overall, calpain-2 mRNA was 12 times higher than calpain-1 
mRNA in the rat retina (Tamada, Nakajima et al. 2005). In the human retina, calpain-
1 and calpain-2 were both detected at the mRNA and protein level. Calpain-1 overall 
had higher mRNA levels compared to calpain-2 in the inner retina. Both were relative 
highly expressed in the inner retina, compared to the outer retina, although the fold 
difference was much greater for calpain-1 suggesting that the mRNA is much higher 
in the RGCs compared to the photoreceptors. This was also indicated by gene arrays 
analysis, which showed that calpain-1 had a significantly higher expression (2.03 
fold) in the RGCL samples compared to entire retinal macular region.  
 
Interestingly, when calpain-1 was investigated using immunohistochemistry, it 
distributed throughout the retina, from the OPL to the RGCL.  This is not inconsistent 
with the mRNA profile data, which showed a wider expression than THY-1 indicating 
localization in the INL. The immune-staining in the OPL could result from expression 
in cells whose nuclei are located in the INL, but synapse in the OPL, specifically the 
amacrine and bipolar cells. It also may be present in Müller cells. Note that mRNA 
for the protein would be associated with the cell body, independently of where the 
protein is expressed. For calpain 2, the assessment of the antigen in the human retina 
displayed exclusively staining in the RGCL, This is surprising and is not consistent 
with the mRNA profile data, which indicates that there is expression in all layers, 
including in the photoreceptors. Further work would need to be done here to look into 
this inconsistency in more detail.   
 
It has been proposed that retinal ischemic insult leads to an excessive increase in 
extracellular glutamate, which results in a sustained activation of glutamate receptors 
and followed by greater Ca2+ entry into cells (Osborne, Casson et al. 2004). In 
addition, it has been shown in the human retina, that simulated ischemia leads to 
activation of P2X7 receptors, which would also lead to increased calcium in the RGCs 
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(Niyadurupola, Sidaway et al. 2013). Therefore, the calcium-dependent proteases, 
such as calpain, could be activated. There is good evidence that increased Ca2+ indeed 
causes RGC death (Hartwick, Hamilton et al. 2008; Araie and Mayama 2011) and 
apoptosis has been observed (Osborne, Wood et al. 2004; Sappington, Sidorova et al. 
2009; Crish and Calkins 2011). Also, calpain-2 activation has been observed in rat 
retinal neurons treated with glutamate (Miao, Dong et al. 2012).  
 
In our experiments presented in this chapter, both 3 hours and 12 hours OGD 
protocols significantly increased LDH release compared with their control samples. 
Therefore, this simulated ischemia-reperfusion model in HORCs led to retinal cell 
damage. To show that proteolysis was induced in this model, α-spectrin and SBDPs 
were assessed at different OGD exposures. Proteolytic activities were greater as the 
OGD time increased with intact spectrin levels decreasing and levels of spectrin 
breakdown products increasing as the severity of the simulated ischemia increased.  
 
Since it was been found that both calpain-1 and 2 were mainly expressed in the inner 
retina, and particular in the RGCL this was consistant with a possible role for these 
enzymes in the RGC cell death observed with simulated ischemia. MDL28170 is an 
inhibitor of both calpain-1 and 2 and was chosen to examine its protective effects in 
the OGD model in HORCs. It has been identified that MDL28170 is a highly cell-
permeable molecule, which has been shown to inhibit ischemic damage in the brain 
(Lia, Howlett et al. 1998; Markgraf, Velayo et al. 1998; Brana, Benham et al. 1999; 
Rami, Agarwal et al. 2000; Kawamura, Nakajima et al. 2005). Specially, it reduced 
infarct volume in rat cerebral ischemia, and its protective activity extended after the 
induction of ischemia, still being effective if applied 6 hours after the brain initial 
ischemia (Markgraf, Velayo et al. 1998). Its pharmacodynamic half-life was around 2 
hours and peak reaction was obtained after 30min (Markgraf, Velayo et al. 1998). Its 
neuroprotective role is achieved by inhibiting cell apoptosis and necrosis (Kawamura, 
Nakajima et al. 2005).  
 
In HORCs, MDL28170 significantly inhibited spectrin degradation of both the 145 
kDa and 150kDa fragments. The 145 kDa fragment is produced specifically by 
calpain activation, so these results suggested that calpain was indeed activated in the 
HORC simulated ischemia model. LDH release following 3 hours OGD/21 hours 
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reperfusion was increased compared to control, but MDL28170 failed to prevent the 
retinal cell damage from the ischemia insult. The number of NeuN-labeled neuronal 
cells in the RGCL and THY-1 mRNA were used to determine the effect of 
MDL28170 specifically in relation to the RGCs. RGC number was significantly 
reduced after 3 hours ischemia and followed by 21 hours reperfusion and THY-1 
mRNA level decreased. The inhibitor slightly prevented RGCs lost but this did not 
reach significance. THY-1 mRNA did not enable detection of any protection of 
MDL28170.  These data would indicate that calpain-induced proteolysis was not part 
of the mechanism mediating RGC death in simulated ischemia, although this is 
unexpected and it would be important to carry out further work to confirm this. It is 
possible that other signaling pathway activated by Ca2+ are more significant in 
ischemia-induced cell death, including caspase-mediated pathways (Wang 2000).  
 
Therefore, both calpain-1 and 2 are confirmed to be present in the human retina. Our 
simulated ischemia model of human retina culture can stimulate their action. Calpain 
activity appeared to be inhibited by 20 µM MDL28170 in the 3 hours simulated 
ischemia insult of HORCs. However, RGC death was not significantly reduced by 
experimental inhibition of calpain activity, and it therefore remains inconclusive 
whether calpain activity involved in the RGC death observed in this model.  
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Chapter 6 
TRP channels in the human retina and role in ischemia-
mediated RGC death 
 
6.1 Introduction 
The previous chapter has identified that calpain activation was stimulated by 3 hours 
OGD in HORCs, which was suggested [Ca2+]i was elevated prior to calpain activation. 
TRP channels are a large group of ion channels containing seven subfamilies (Nilius, 
Owsianik et al. 2007; Dadon and Minke 2010). They play a crucial role in modulation 
of the cytosolic Ca2+ concentration but are also implicated in the pathophysiology of 
numerous diseases (CLAPHAM 2005; Clapham 2007; Nilius, Owsianik et al. 2007; 
Venkatachalam and Montell 2007).  
 
The TRP superfamily is divided into subfamilies based on their structure and function: 
TRPC (canonical), TRPV (vanilloid), TRPM (melastatin), TRPP (polycystin), 
TRPML (mucolipin), TRPA (ankyrin) and TRPN (NOMPC) (Clapham 2005). These 
are further subdivided giving 28 different subtypes.   
 
Expression of all 28 TRP channels has been demonstrated in the mammalian retina 
(Gilliam and Wensel 2011) indicating their importance to retinal physiology. The 
distribution of TRP channels in the human retina has not been studied, but the 
expression of different TRP subunits has been shown to vary in different cell types of 
the rodent retina (Crousillac, Lerouge et al. 2003; Gilliam and Wensel 2011). There 
are some members from the TRPC and TRPV families that have been proposed to 
play a significant role in glaucoma (Sappington, Sidorova et al. 2009; Ryskamp, 
Witkovsky et al. 2011; Pan, Capó-Aponte et al. 2012). TRPC-6 was found to have a 
RGC protective role against ischemia/ reperfusion early injury when the channel was 
activated prior to ischemia (Wang, Teng et al. 2010). TRPV-1 and TRPV-4 activities 
contribute to RGC apoptosis (Sappington, Sidorova et al. 2009; Ryskamp, Witkovsky 
et al. 2011).  
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The TRPC family is the one of the most widely studied TRP channels. It includes 
seven members, TRPC1 -7 (Table 5.1). Except TRPC-2, which is a pseudo gene, the 
rest of the TRPC channels are extensively expressed in brain where they play critical 
roles in neuronal cell differentiation, proliferation and survival (Dadon and Minke 
2010; Shapovalov, Lehen’kyi et al. 2011). Their activities are also implicated in 
neuronal degeneration diseases, such as Parkinson's Disease, Alzheimer's Disease and 
Cerebellar Ataxia (Selvaraj, Sun et al. 2010). TRPC channels are nonselective cation 
channels, which are permeable to Ca2+ and Na+(Nilius, Owsianik et al. 2007). The 
TRPC channels are mainly activated by the PLC pathway, via G protein–coupled 
activation (PLC-β) or receptor tyrosine kinase (RTK) activation (PLC-γ). IP3 and 
DAG can also regulate calcium influx through some TRPC channels (Selvaraj, Sun et 
al. 2010).  
 
The TRPM (melastatin) family of TRP channels has 8 members (TRPM1-8). TRPM-
1 was the first member of TRPM family to be identified in mammalian retina. It was 
found that TRPM-1 is involved in on-pathways in the human retina, being expressed 
in ON-bipolar cells and at the synaptic ribbons of some rods (Klooster, Blokker et al. 
2011). Mutation of TRPM-1 in the human retina leads to night blindness (Genderen, 
Bijveld et al. 2009). The role of TRPM-2 in brain ischemia has been widely 
investigated, and it has been suggested that inhibition of TRPM-2 has the potential to 
protect against neuronal cell death in ischemic conditions (Simard, Tarasov et al. 
2007; Szydlowska and Tymianski 2010). However, its role in RGC death has not been 
studied.  
 
TRPC-3 (Miller 2006) and TRPM-2 are both activated by cellular oxidative stress 
(Herson and Ashford 1997; Smith, Herson et al. 2003) and both lead to raised 
intracellular Ca2+ concentration when they were activated. Oxidative stress is one of 
important reasons contributes to ischemic neuronal injury (Verma, Quillinan et al. 
2012) and there is increasing evidences suggest that oxidative stress involves in RGC 
death in glaucoma (Qu, Wang et al. 2010; Crish and Calkins 2011; McElnea, Quill et 
al. 2011) and there are parallels drawn between neurodegeneration following ischemia 
in the brain and RGC degeneration in glaucoma. 
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In summary, there have been several papers relating to the role of TRP channels in 
RGCs (Crousillac, Lerouge et al. 2003; Sappington, Sidorova et al. 2009; Wang, Teng 
et al. 2010; Pan, Capó-Aponte et al. 2012). They play a major role in Ca2+ 
homeostasis and are gated by mechanisms that relate to the pathophysiology of 
glaucoma, including mechanical stress and oxidative stress (Pan, Capó-Aponte et al. 
2012). Therefore, although they were not identified from the gene array data, a series 
of experiments were carried out to look at these in more detail in the human retina.   
In this chapter the methods described in the previous chapter were used to 
investigated the expression of the TRP channels TRPC-1, TRPC-3 and TRPM-2. In 
addition, a TRP inhibitor (N-(p-amylcinnamoyl) anthranilic acid; ACA) was used to 
see if it could inhibit RGC death in a human model of retinal ischemia. 
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6.2 Result: 
6.2.1 mRNA levels of TRPM-2, TRPC-1 and -3 in the human macula. 
The cryosectioning technique, described in Chapter 3, was used to assess expression 
of the TRP channels TRPC-1, TRPC-3 and TRPM-2. TRPC-1, TRPC-3 and TRPM-2 
mRNA were all expressed in the human retina (Figure 6.1). Compared to the other 
two TRP channel mRNA investigated, TRPC-1 had a relatively low expression. It 
was expressed throughout the retina, with a slightly higher expression in the outer 
retina compared to the inner retina. Its lowest level was in the innermost four sections, 
which were the sections showing highest expression of THY-1. The distribution of 
TRPC-3 and TRPM-2 showed almost identical expression patterns. They were both 
most highly expressed in the inner retina sections and nearly absent in the outer retina. 
Their expressions associated closely with THY-1 expression indicating that 
expression may be exclusive to RGCs. 
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Figure 6.1 Relative mRNA expression of TRPC-1, TRPC-3 and TRPM-2 in serial sections 
of human retina. Data was normalized relative to the section with the highest mRNA (n= 5 
donor eyes, mean± S.E.M.) 
 
 
6.2.2 Immunoreactivity of TRPM-2 in the retina 
The distribution of TRPM-2 was assessed in the human retinal macula by 
immunohistochemistry. To verify TRPM-2 distribution, NeuN was used to compare 
with the TRPM-2 expression. TRPM-2 immunoreactivity was observed that it 
exclusively occurred in the RGCL, and staining coincided with that for NeuN (Figure 
6.2). This provided further evidence that TRPM-2 channel mainly or specially existed 
in the human RGCL and that human RGCs express TRPM-2. 
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Figure 6.2 Photomicrographs of immunohistochemistry of the human macula with 
NeuN and TRPM-2 staining. Section was co-labeled with RGC marker, NeuN (green), and 
TRPM-2 (red), and the nuclear was stained with DAPI (blue). 
 
 
6.2.3 Simulated ischemia induced cell death in HORCs and treated with the TRP 
inhibitor, ACA 
HORCs were incubated under condition of oxygen and glucose deprivation (OGD) 
for 3 hours followed by a 21 hours “reperfusion” in normal medium. Initial 
experiments measured LDH leakage into the medium. This is a measure if overall cell 
death caused by simulated ischemia.  
 
HORCs exposed to 3 hours OGD-21 hours reperfusion caused a significant increase 
in LDH leakage compared to control (Figure 6.3). This was not inhibited by 20 µM 
ACA. However, 20 µM ACA alone caused a small but statistically significant 
increase in LDH release compared with control. This suggested that 20 µM ACA 
might be toxic to the human retina. LDH release gives information about cell death, 
but does not indicate which cells are involved. It is known that simulated ischemia 
causes a loss of RGCs. Furthermore, TRPM-2 and TRPC-3 appear to be the expressed 
exclusively in RGCs. It was therefore of interest to look specifically at the effect of 20 
µM ACA on RGC survival.  
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Figure 6.3 LDH release from HORCs in simulated ischemia in the presence and 
absence of 20 µM ACA. LDH levels in the medium from the reperfusion phase in control 
HORCs with/without 20 µM ACA and 3 hours/21 hours OGD/reperfusion with/without 20 µM 
ACA (n=5 donor eyes, mean ± S.E.M.). ** P<0.01, * P<0.05 vs control. 
 
 
6.2.4 Involvement of TRP channels in simulated ischemia induced RGC death in 
HORCs 
In order to investigate whether the TRP inhibitor, ACA, protected RGCs against 
simulated ischemic insults, NeuN immunohistochemistry was carried out to assess 
RGC number in RGCL after the HORCs were exposed to 3 hours OGD/21 hours 
reperfusion. Immunohistochemical images showed that the number of NeuN-positive 
cells in the RGCL was decreased when HORCs were exposed to 3 hours OGD/21 
hours reperfusion compared to 24 hours control (Figure 6.4). Cell counts showed a 
significant decrease in NeuN-positive cells in the RGCL of simulated ischemia 
HORCs, compared to the 24 hours control (Figure 6.4B). In the presence of 20 µM 
ACA alone, NeuN-positive cell number was slightly increased compared with control 
(Figure 6.4B), although this increase was not significant. Furthermore, with 
application of ACA, the numbers of NeuN-positive cells were slightly increased, 
although again they were not found to be significant (Figure 5.5A and B).  
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Figure 6.4 (A) Representative immunohistochemical images of HORCs with simulated 
ischemia in the presence and absence of 20 µM ACA. RGCs were labeled with antibody to 
NeuN (Red), TUNEL staining for apoptosis is shown in Green, and nuclei are stained with 
DAPI (blue). IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; 
ONL, outer nuclear layer. (B) Counts of NeuN labelled cells in the RGCL in the control with 
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and 20 µM ACA, 3 hours/21 hours OGD/reperfusion with and without 20 µM ACA (mean ± 
S.E.M.; n=4 donor eyes). * p<0.05 vs control. 
 
 
RGC number was also assessed by measuring THY-1 mRNA. Exposure of HORCs to 
3h OGD-21h reperfusion led to a significant decrease in THY-1 mRNA compared 
with the 24h control (Figure 6.5). The addition of 20µM ACA alone increased THY-1 
mRNA level in the control HORCs. In addition, 20µM ACA added to HORCs with 
3h OGD-21h reperfusion treatment, caused an increased THY-1 mRNA expression, 
although again this was not statistically significant.  
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Figure 6.5 THY-1 level in 3h/21 h OGD/reperfusion treated HORCs in the presence and 
absence of 20µM ACA. THY-1 mRNA expression was normalised to the geometric mean of 
TOP-1 and CYC-1 mRNA expression and expressed relative to control, (mean ± S.E.M.; n= 4 
donor eyes). * p<0.05 vs control. 
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6.3 Discussion 
Although IOP is the main risk factor of glaucoma, there is more and more evidence 
indicating that reduced blood supply is involved in the pathophysiology of glaucoma 
(Flammer, Orgul et al. 2002; Grieshaber and Flammer 2005; Yanagi, Kawasaki et al. 
2011). Reduced blood flow in the retina will consequently result in ischemia, a deficit 
of oxygen and glucose (OGD) in the retina, which has a close link with RGC death 
(Osborne, Casson et al. 2004; Kaur, Foulds et al. 2008; Osborne 2010). There are 
multiple factors involved in pathological processes, deregulation of Ca2+ homeostasis 
is one of the critical events contributes to RGC death.  
 
Disruption of Ca2+ homeostasis is a frequent phenomenon induced by the anoxic 
condition which leads to neuronal cell death and increasing evidence suggests that 
TRP channels have a significant contribution to that process (Venkatachalam and 
Montell 2007). TRPC-1, TPRC-3 and TRPM-2 are highly expressed in the brain, 
however, their distribution in the retina is not clear. For the initial experiments the 
expression profile of mRNA of these three TRP channels was investigated. The data 
indicated that TRPC-3 and TRPM-2 were highly expressed in the RGCL with no 
evidence of any expression in the photoreceptors. TRPC-1 was expressed throughout 
the retina, with higher amounts in the outer retina, which is similar as the observation 
in the mouse retina (Gilliam and Wensel 2011). Immunohistochemistry data further 
verified TRPM-2 localization, with TRPM-2 immunoreaction appeared to be 
exclusively located in RGCL and corresponding with NeuN positive cell in the RGCL 
and INL. Unfortunately available antibodies for the TRPC channels investigated are 
not good (Gilliam and Wensel 2011), therefore verification of localization of these 
channels was not possible by immunohistochemistry. 
 
TRPM-2 has been shown to mediate hypoxia-induced neuronal cell death in the brain 
and inhibition of TRPM-2 activity had a neuroprotective role (Venkatachalam and 
Montell 2007; Gees, Colsoul et al. 2010). Whether the TRPM-2 could be involved in 
RGC death has not been investigated. Therefore, the HORC model was used to 
investigate TRPM-2 involvement under the oxygen and glucose deprivation 
conditions (simulated ischemia). The inhibitor ACA was used.  ACA is an inhibitor of 
TRPM-2 which almost completely blocked current through TRPM-2 channel in 
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HEK293 cells (Kraft, Grimm et al. 2006). It is, however, not totally selective; several 
other human TRP channels are also sensitive to ACA (Harteneck, Frenzel et al. 2007) 
with the activities of TRPM-8, TRPC-6, TRPC-3/5 and TRPV-1/4 being found to be 
affected (Kraft, Grimm et al. 2006). 
 
Measuring the LDH accumulation in the culture medium presents an overall 
assessment of retina damage. LDH releasing in HORCs was increased in simulated 
ischemia. Application of the TRPM-2 inhibitor, 20µ M ACA, did not suppresses the 
LDH, in fact there was a slightly increase in LDH in the presence of ACA, which may 
suggest some toxicity. Focussing specifically on RGC viability of ischemia, 20 µM 
ACA inhibited the loss of NeuN-positive cells, giving about 50% protection to RGCs. 
However, statistical significance was not reached. Decreased mRNA of the RGCs 
marker, THY-1, supported the data of RGC number changes. 3 hours OGD led to a 
significant loss of THY-1 mRNA, which was about 17% decrease. Application of 20 
µM ACA to HORCs prevented the loss of THY-1 mRNA and in fact, the OGD/ACA 
treated HORCs had higher levels of THY-1 than control. However, the protection was 
not shown to be statistically different from OGD alone. This indicated that 20 µM 
ACA is possibly protective to RGCs, although again, this was not statistically 
significant. There are several factors which might impact the data significance. 3h 
OGD caused a small decrease (<25%) in both NeuN-positive and THY-1 
measurements. Carrying out more repeats may have improved the significance, but 
when using human tissue this is difficult. Also, the personal variations of each donor 
may increase variability.   
 
In the present experiments, TRPC-3 and also TRPM-2 were expressed in the inner 
retina and their pattern of distribution was consistent with expression exclusively in 
RGCs. The experiments presented here suggest that their activation might be involved 
in ischemia induced RGC death, however, more work needs to be done to confirm 
this. Meanwhile, the P2X7 has been shown to contribute to RGC death in this model, 
(Niyadurupola, Sidaway et al. 2013) and it will be interesting to look at interaction 
between these channels in mediating Ca2+ overload and RGC death.  
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Chapter 7 
General Discussion 
 
The aim of this study was to investigate Ca2+ signaling pathways in relation to retinal 
ganglion cell (RGC) death in glaucoma using the human retina. This involved the use 
of human organotypic retinal cultures (HORCs), a system that has been validated 
under conditions of simulated ischemia (Niyadurupola, Sidaway et al. 2011). 
Moreover, a novel planar sectioning technique was successfully developed and used 
to analyze expression of genes which were predominately distributed in human RGC 
layer. Several Ca2+ related genes were identified.  
 
The major achievement of this study was the development of the novel sectioning 
technique. This planar sectioning method was able to collect a high quantity of high 
quality mRNA from each single layer from retina. mRNA from the RGC layer was 
collected and compared with entire retinal macula. The mRNA distributions of 
different retinal cell markers, recoverin (RCVRN) for photoreceptors (Dizhoor, Ray et 
al. 1991), calbindin (CALB) for horizontal cells, choline acetyltransferase (CHAT) for 
amacrine cells (Haverkamp and Wassle 2000) and Thy-1 (Barnstable and Drager 
1984), NeuN (Buckingham, Inman et al. 2008) and Brn3a (Nadal-Nicolas, Jimenez-
Lopez et al. 2009) (THY-1, RBFOX3 and POU4F1) for RGCs, were measured in the 
human macula. They showed distinct distributions through the retinal layers which 
were consistent with the known distribution of the cells. At present, application of 
specific antibodies to retinal sections is the most common way to investigate 
distribution (Johansson, Eftekhari et al. 2010; Siegert, Cabuy et al. 2012). However, 
this is difficult to quantify and also depends on the antibody quality which can be very 
variable. PCR allows the use of very specific probes and together with the sectioning 
technique gives valuable information about the distribution of genes in the retina.   
 
In order to be able to understand the advanced cellular and molecular events that 
might be involved in glaucoma pathophysiology, it is of great value to determine the 
gene expression profile of human RGCs. Therefore, this technique was further used to 
collect RGC layer mRNA from macular region of the retina. Global gene expression 
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of RGC layer was compared with entire retinal macula using Illumina gene arrays. 
There were a large number of genes that were predominantly or exclusively expressed 
in the RGC layer, and some of these had not been linked previously with RGCs. 
AHNAK2 and HSPA1B (HSP70-2) were the two genes which were found to have 
highest expressed in the RGC layer. These results were verified by both QRT-PCR 
and immunolocalization. AHNAK2 presented a distribution which was exclusive to 
the RGC layer and absent in other retinal layers. Therefore, the data presented in this 
thesis has identified a potential new specific markers for human retinal ganglion cells. 
 
HSPA1B (the gene for heat shock 70kDa protein 1B) had a similar distribution in the 
inner retina to THY-1 at mRNA level, but it also had some expression in the outer 
retina. This was consistent with its protein immunolocalization in the macula. HSP70 
functions as a chaperone molecule to supervise protein denaturation, translocation, 
correct folding, activation and aggregation (Takayama, Reed et al. 2003). HSP70 has 
a potential neuroprotective function when over-expressed and has been shown to 
protect some neuronal cells from certain stressful insults (Yenari, Giffard et al. 1999). 
A recent report has indicated that HSP70 is specifically expressed in RGCs and is the 
earliest gene induced after optic nerve injury, and is crucial for RGCs survival in the 
zebra fish retina (Nagashima, Fujikawa et al. 2011). Heat shock 70kDa protein 8 
(HSPA8 or HSC70), shares 85% sequence homology with HSP70 and has similar 
functions to the other members of HSP70 family (Liu, Daniels et al. 2012) and was 
also found to be enriched in human RGCs. HSP70 and HSC70 expression was also 
enhanced after cerebral ischemia (Muranyi, He et al. 2005). Furthermore, 
administration of HSP/HSC70 to the neonatal mouse with traumatic injury can reduce 
subsequent apoptotic loss of neurons (Tidwell, Houenou et al. 2004). The finding that 
HSP70 is highly expressed in human macula provides important evidence for the 
contribution of heat shock protein in neuroprotective function within retinal neurons 
in the human retina, particularly RGCs. It would be interesting to compare expression 
of this protein in retinas from different donors. Is HSP70 always present in human 
retina or is it expressed because it has been induced due to events that occurred to the 
retina during the donor’s life?  Looking at expression with age would be interesting in 
this respect.   
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Several animal models in rat and monkey, have been used to investigate global gene 
expression in RGCs. Purified RGCs using immunopanning was a popular approach 
for RGCs gene expression research. The method uses enzymes to digest the 
connections between RGCs and other cells and involves a period where the cells are 
in culture before being analysed. Potential drawbacks to the process include changes 
to the ganglion cell as a result of the culture period, in addition to the effect of the 
enzyme during the dissociation procedure. These factors could potentially change the 
gene expression pattern. It should be noted here that we have tried to isolate RGCs 
from human retina using this method, but it was not successful. 
 
Recently, laser capture microdissection (LCM) was used as a powerful and precise 
way to capture the RGCs in the RGCL. Kim et al used this technique to investigate 
the gene expression profile of human adult RGCs (Kim, Kuehn et al. 2006).  
However, their methods had a number of drawbacks. Compared with our method, 
they used the para-macular region, which contained a much thinner RGCL and fewer 
RGCs. Importantly, the ratio of RGCs to other cell types is much higher in this region 
compared to the macula, therefore the sample used in those experiments was not 
highly enriched for RGCs. In addition, LCM does not yield much RNA, so they 
needed a separate amplification step, which could potentially introduce some errors if 
amplification weren’t linear for all of the genes. Another point to consider was that 
the gene array list was compiled by comparing gene expression of RGCs with the rest 
of the retina and all of the retina beyond the IPL was taken. In the experiments 
described in this thesis, only the samples from the sections with highest expression of 
RGC markers were taken. Therefore, for several reasons, the sample we used was 
much more enriched for RGC mRNA and therefore the gene list is likely to be a much 
more accurate reflection of expression in human RGCs. 
 
There were a large number of interesting genes were found out that expressed in the 
RGCL. Some calcium-related genes were found to be highly expressed in RGC layer 
by the gene array data. Calpain-1 was one of these genes. Calpain is a calcium-
dependent cysteine protease (Johnson and Guttmann 1997; Sorimachi and Ono 2012). 
Calpain-1 (µ-calpain) and calpain-2 (m-calpain) are the two ubiquitously distributed 
and most extensively studied isoforms of calpain. QRT-PCR showed that CAPN1 had 
a more advanced expression level and was dominant in the RGC layer which was 
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consistent with it distribution in the rabbit retina (Croall and Demartino 1991). It has 
been found that calpain activation involved in ischemia/hypoxia-induced retinal cell 
death in both in vivo (Sakamoto, Nakajima et al. 2000; Tamada, Nakajima et al. 
2005) and in vitro of animal models (Tamada, Fukiagea et al. 2002; Tamada, 
Nakajima et al. 2005), and also in the experimental model of glaucoma (Huang, Fileta 
et al. 2010). In the HORCs model, both 3 hours and 12 hours OGD protocols 
increased LDH release which showed that the simulated ischemia led to retinal cell 
damage. In order to determine whether proteolysis was induced by calpain activation 
in this model, α-spectrin and SBDPs were assessed at different OGD exposures 
periods. Proteolytic activities were greater as the OGD time increased which the intact 
spectrin levels decreased and levels of spectrin breakdown products increased as the 
severity of the simulated ischemia increased.  
 
Since it was found that both calpain-1 and 2 were expressed in the inner retina, and 
particular in the RGCL this was consistent with a possible role for these enzymes in 
the RGC cell death observed with simulated ischemia. MDL28170 is an inhibitor of 
both calpain-1 and 2 and was chosen to examine its protective effects in the OGD 
model in HORCs. It has been identified that MDL28170 is a highly cell-permeable 
molecule, which has been shown to inhibit ischemic damage in the brain (Lia, 
Howlett et al. 1998; Markgraf, Velayo et al. 1998; Brana, Benham et al. 1999; Rami, 
Agarwal et al. 2000; Kawamura, Nakajima et al. 2005). Specially, it reduced infarct 
volume in rat cerebral ischemia, and its protective activity extended after the 
induction of ischemia, still being effective if applied 6h after the brain initial ischemia 
(Markgraf, Velayo et al. 1998). The pharmacodynamic half-life was around 2 hours 
and peak reaction was obtained after 30 minutes (Markgraf, Velayo et al. 1998). Its 
neuroprotective role is achieved by inhibiting cell apoptosis and necrosis (Kawamura, 
Nakajima et al. 2005). In the HORCs, MDL28170 significantly inhibited appearance 
of both the 145 kDa and 150 kDa spectrin breakdown products, which indicated that 
calpain was indeed activated in the HORC simulated ischemia model. However, 
MDL28170 failed to prevent the retinal cell damage from the ischemic insult. RGC 
number was significantly reduced after 3 hours ischemia and followed by 21 hours 
reperfusion and THY-1 mRNA level decreased. The inhibitor slightly prevented RGCs 
loss but this did not reach significance. THY-1 mRNA did not enable detection of any 
protection of MDL28170. Therefore, it was concluded that calpain-induced 
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proteolysis was not part of the mechanism mediating RGC death in simulated 
ischemia. This, however, was unexpected and it would be important to carry out 
further work to confirm this. It is possible that other signaling pathway activated by 
Ca2+ are more significant in ischemia-induced cell death, including caspase-mediated 
pathways (Wang 2000). Also the retinal-specific calpain may play a role – the activity 
of MDL28170 at this enzyme is not known. 
 
It is interesting to speculate about the correlation between heat shock proteins and 
calpain activation. It was shown in the research presented in this thesis that several 
members of the heat shock protein family were predominantly in the RGCs. Some 
previous reports have indicated that antibody titers to HSPs were elevated in serum, 
aqueous humor and the optic nerve head in the glaucoma patient (Tezel, Hernandez et 
al. 2000; Joachim, Bruns et al. 2007a; Joachim, Wuenschig et al. 2007b). In addition, 
it has been shown that the small heat shock proteins (aA- and aB-crystallin and 
HSP27) are elevated in glaucoma patients, and that this is greater in normal pressure 
glaucoma patients compare to those with primary open angle glaucoma (Tezel, Seigel 
et al. 1998; Wax, Tezel et al. 2000). It has also been demonstrated that in 
experimental glaucoma that there is increased expression of HSPs, particular HSP27, 
in both retinal ganglion cells and glial cells (Huang, Fileta et al. 2007) and that in 
cultured rat RGCs increased HSP72 expression is seen after hyperthermia (42 °C, 1 
hour) and hypoxia (6 hours) treatment (Caprioli, Kitano et al. 1996). Furthermore, 
these pretreated cells were then found to have greater resistance to anoxia (6 hours) or 
glutamate treatment (6 hours) (Caprioli, Kitano et al. 1996). All these findings suggest 
that HSPs are assisting RGCs in maintenance of cell function and resisting the 
stressful insults of glaucoma. Calpain activation can lead to the breakdown of 
hundreds of protein substrates, such as cytoskeletal proteins, membrane-associated 
proteins, transcription factors, kinases and phosphatases (Goll, Thompson et al. 2003). 
There is some evidence that HSPs are substrates of calpain proteolysis, and an 
association between calpain activation, HSP70 cleavage and neuronal death in brain 
ischemia has been proposed (Yamashima and Oikawa 2009; Yamashima 2012). 
HSP70 is the highest expressed gene in the RGCL. Therefore if calpain broke down 
the HSP70 and HSP70 was protecting the cells, this would be detrimental to the 
RGCs. 
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The experiments presented in chapter 5, show that calpain activity was induced by 
simulated ischemia, which in turn indicates that calcium influx was elevated by OGD.   
It was therefore interesting to look at channels which mediate Ca2+ influx. The P2X7 
receptor has previously been studied in the lab and the techniques developed in this 
thesis were successfully used to investigate distribution of the P2X7 receptor 
(Niyadurupola, Sidaway et al. 2013). This data was not included in this thesis, but the 
paper is attached in Appendix 1. The only plasma membrane Ca2+ conducting channel 
that appeared in the list of most highly expressed genes in human RGCs was the 
NMDA receptor. This, however, has been intensively studied in the retina previously, 
so it was decided to look at channels that did not have extensive literature in the retina. 
TRPC-1, TRPRC-3 and TRPM-2 are highly expressed in the brain (Venkatachalam 
and Montell 2007), however, their distributions in the retina are not clear. For the 
initial experiments the mRNA of the three TRP channels was investigated, and the 
data indicated that TRPC-3 and TRPM-2 were highly expressed in the RGCL. TRPC-
1 was more expressed in the outer retina, which is similar to that observed in the 
mouse retina (Gilliam and Wensel 2011). Unfortunately, the available antibodies for 
the TRPC channels are not reliable (Gilliam and Wensel 2011). However, the TRPM-
2 antibody worked well in the human retina and immunoreactivity was exclusively 
located in the RGCL and corresponded with NeuN-positive cells. TRPM-2 mediates 
neuronal cell death in brain when it was induced by hypoxic conditions and inhibition 
of TRPM-2 activity indicated a neuroprotective role (Venkatachalam and Montell 
2007; Gees, Colsoul et al. 2010). However, its contribution to human retinal ischemia 
was unknown. The present experiments using the inhibitor ACA were inconclusive.  
This inhibitor is reported as a TRPM-2 inhibitor, but it also inhibits a number of other 
TRP channels, including TRPC-3 (Kraft, Grimm et al. 2006). Any inhibition observed 
could therefore not be attributed to inhibition of one particular TRP channel.  
Furthermore, the experiments themselves were inconclusive. LDH leakage of HORCs 
cultured with ACA did not protect against retinal cell death.  When RGC viability was 
looked at directly by assessing the number of NeuN-positive cells and levels of THY-1 
mRNA, in each case there appeared to be a protection, but statistical significance was 
not achieved.  Despite advantages of the HORC system, including that fact that it uses 
human retina, a drawback is that it is likely to be more variable and also the supply 
means that it is not possible to carry out large numbers of repeats. The current 
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experiment data did imply that TRP channel activation may contribute to ischemia 
induced RGC death, but more research would need to be carried out to confirm this. 
 
This research has therefore developed novel techniques for studying the human retina, 
enabling identification of novel RGC markers and also genes that might be involved 
in glaucoma pathophysiology. In the future, this may help to identify targets for 
development of novel neuroprotective strategies for treatment of glaucoma. 
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